false00018368752025Q312/310.50.0250.0250.50.10.13111P5Y501.10.0250.10.1http://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2025#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#RevenueFromContractWithCustomerExcludingAssessedTaxhttp://fasb.org/us-gaap/2025#RevenueFromContractWithCustomerExcludingAssessedTaxhttp://fasb.org/us-gaap/2025#RevenueFromContractWithCustomerExcludingAssessedTaxhttp://fasb.org/us-gaap/2025#RevenueFromContractWithCustomerExcludingAssessedTaxP6M0.50.025xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesnvve:subsidiaryxbrli:purenvve:membership_unitnvve:memberiso4217:EURnvve:paymentutr:Dnvve:class_of_stockutr:sqft00018368752025-01-012025-09-300001836875us-gaap:CommonStockMember2025-01-012025-09-300001836875us-gaap:WarrantMember2025-01-012025-09-3000018368752025-11-0800018368752025-09-3000018368752024-12-310001836875us-gaap:NonrelatedPartyMember2025-09-300001836875us-gaap:NonrelatedPartyMember2024-12-310001836875us-gaap:RelatedPartyMember2025-09-300001836875us-gaap:RelatedPartyMember2024-12-310001836875us-gaap:ProductMember2025-07-012025-09-300001836875us-gaap:ProductMember2024-07-012024-09-300001836875us-gaap:ProductMember2025-01-012025-09-300001836875us-gaap:ProductMember2024-01-012024-09-300001836875us-gaap:ServiceMember2025-07-012025-09-300001836875us-gaap:ServiceMember2024-07-012024-09-300001836875us-gaap:ServiceMember2025-01-012025-09-300001836875us-gaap:ServiceMember2024-01-012024-09-300001836875us-gaap:GrantMember2025-07-012025-09-300001836875us-gaap:GrantMember2024-07-012024-09-300001836875us-gaap:GrantMember2025-01-012025-09-300001836875us-gaap:GrantMember2024-01-012024-09-3000018368752025-07-012025-09-3000018368752024-07-012024-09-3000018368752024-01-012024-09-300001836875us-gaap:CommonStockMember2024-12-310001836875us-gaap:TreasuryStockCommonMember2024-12-310001836875us-gaap:AdditionalPaidInCapitalMember2024-12-310001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001836875us-gaap:RetainedEarningsMember2024-12-310001836875us-gaap:NoncontrollingInterestMember2024-12-310001836875us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-3100018368752025-01-012025-03-310001836875us-gaap:CommonStockMember2025-01-012025-03-310001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001836875us-gaap:RetainedEarningsMember2025-01-012025-03-310001836875us-gaap:NoncontrollingInterestMember2025-01-012025-03-310001836875us-gaap:PreferredClassAMemberus-gaap:MemberUnitsMember2025-03-310001836875us-gaap:CommonClassBMemberus-gaap:MemberUnitsMember2025-03-310001836875us-gaap:CommonStockMember2025-03-310001836875us-gaap:TreasuryStockCommonMember2025-03-310001836875us-gaap:AdditionalPaidInCapitalMember2025-03-310001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001836875us-gaap:RetainedEarningsMember2025-03-310001836875us-gaap:NoncontrollingInterestMember2025-03-3100018368752025-03-310001836875us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-3000018368752025-04-012025-06-300001836875us-gaap:CommonStockMember2025-04-012025-06-300001836875us-gaap:PreferredClassAMemberus-gaap:MemberUnitsMember2025-04-012025-06-300001836875us-gaap:PreferredClassAMember2025-04-012025-06-300001836875us-gaap:CommonClassBMemberus-gaap:MemberUnitsMember2025-04-012025-06-300001836875us-gaap:CommonClassBMember2025-04-012025-06-300001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300001836875us-gaap:RetainedEarningsMember2025-04-012025-06-300001836875us-gaap:NoncontrollingInterestMember2025-04-012025-06-300001836875us-gaap:PreferredClassAMemberus-gaap:MemberUnitsMember2025-06-300001836875us-gaap:CommonClassBMemberus-gaap:MemberUnitsMember2025-06-300001836875us-gaap:CommonStockMember2025-06-300001836875us-gaap:TreasuryStockCommonMember2025-06-300001836875us-gaap:AdditionalPaidInCapitalMember2025-06-300001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001836875us-gaap:RetainedEarningsMember2025-06-300001836875us-gaap:NoncontrollingInterestMember2025-06-3000018368752025-06-300001836875us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300001836875us-gaap:CommonStockMember2025-07-012025-09-300001836875us-gaap:PreferredClassAMemberus-gaap:MemberUnitsMember2025-07-012025-09-300001836875us-gaap:PreferredClassAMember2025-07-012025-09-300001836875us-gaap:CommonClassBMemberus-gaap:MemberUnitsMember2025-07-012025-09-300001836875us-gaap:CommonClassBMember2025-07-012025-09-300001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300001836875us-gaap:RetainedEarningsMember2025-07-012025-09-300001836875us-gaap:NoncontrollingInterestMember2025-07-012025-09-300001836875us-gaap:PreferredClassAMemberus-gaap:MemberUnitsMember2025-09-300001836875us-gaap:CommonClassBMemberus-gaap:MemberUnitsMember2025-09-300001836875us-gaap:CommonStockMember2025-09-300001836875us-gaap:TreasuryStockCommonMember2025-09-300001836875us-gaap:AdditionalPaidInCapitalMember2025-09-300001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001836875us-gaap:RetainedEarningsMember2025-09-300001836875us-gaap:NoncontrollingInterestMember2025-09-300001836875us-gaap:CommonStockMember2023-12-310001836875us-gaap:AdditionalPaidInCapitalMember2023-12-310001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001836875us-gaap:RetainedEarningsMember2023-12-310001836875us-gaap:NoncontrollingInterestMember2023-12-3100018368752023-12-310001836875us-gaap:CommonStockMember2024-01-012024-03-310001836875us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-3100018368752024-01-012024-03-310001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001836875us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001836875us-gaap:RetainedEarningsMember2024-01-012024-03-310001836875us-gaap:CommonStockMember2024-03-310001836875us-gaap:AdditionalPaidInCapitalMember2024-03-310001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001836875us-gaap:RetainedEarningsMember2024-03-310001836875us-gaap:NoncontrollingInterestMember2024-03-3100018368752024-03-310001836875us-gaap:CommonStockMember2024-04-012024-06-300001836875us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-3000018368752024-04-012024-06-300001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001836875us-gaap:NoncontrollingInterestMember2024-04-012024-06-300001836875us-gaap:RetainedEarningsMember2024-04-012024-06-300001836875us-gaap:CommonStockMember2024-06-300001836875us-gaap:AdditionalPaidInCapitalMember2024-06-300001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001836875us-gaap:RetainedEarningsMember2024-06-300001836875us-gaap:NoncontrollingInterestMember2024-06-3000018368752024-06-300001836875us-gaap:CommonStockMember2024-07-012024-09-300001836875us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001836875us-gaap:NoncontrollingInterestMember2024-07-012024-09-300001836875us-gaap:RetainedEarningsMember2024-07-012024-09-300001836875us-gaap:CommonStockMember2024-09-300001836875us-gaap:AdditionalPaidInCapitalMember2024-09-300001836875us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001836875us-gaap:RetainedEarningsMember2024-09-300001836875us-gaap:NoncontrollingInterestMember2024-09-3000018368752024-09-300001836875nvve:NuvveMember2025-09-300001836875nvve:NuvveCorpMember2025-09-300001836875nvve:DeepImpactMembernvve:NuvveMember2024-08-160001836875nvve:DeepImpactMembernvve:WISEEVLLCMember2024-08-160001836875nvve:FermataEnergyIILLCMembernvve:NuvveMember2025-04-250001836875nvve:FermataEnergyIILLCMembernvve:FermataEnergyIILLCPreferredMembersMember2025-04-250001836875nvve:FermataEnergyIILLCMemberus-gaap:PreferredClassAMember2025-04-250001836875nvve:NuvveNewMexicoLLCMemberus-gaap:CommonClassBMember2025-04-300001836875nvve:NuvveNewMexicoLLCMember2025-09-300001836875nvve:NuvveNewMexicoLLCMemberus-gaap:CommonClassBMember2025-09-300001836875srt:MaximumMember2024-01-052024-01-050001836875srt:MinimumMember2024-01-052024-01-0500018368752024-01-192024-01-190001836875srt:MaximumMember2024-09-092024-09-090001836875srt:MinimumMember2024-09-092024-09-0900018368752024-09-162024-09-1600018368752024-01-012024-12-3100018368752023-01-012023-12-310001836875nvve:WISEEVLLCMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2025-01-012025-09-300001836875nvve:LevoMobilityLLCMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2025-09-300001836875nvve:LevoMobilityLLCMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-12-310001836875nvve:LevoMobilityLLCMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:NonrelatedPartyMember2025-09-300001836875nvve:LevoMobilityLLCMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:NonrelatedPartyMember2024-12-310001836875nvve:LevoMobilityLLCMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:RelatedPartyMember2025-09-300001836875nvve:LevoMobilityLLCMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:RelatedPartyMember2024-12-310001836875nvve:TwoCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-07-012025-09-300001836875nvve:TwoCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-09-300001836875nvve:ThreeCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001836875nvve:ThreeCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001836875nvve:TopFiveCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-07-012025-09-300001836875nvve:TopFiveCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-09-300001836875nvve:TopFiveCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001836875nvve:TopFiveCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001836875nvve:ThreeCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-09-300001836875nvve:ThreeCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-12-310001836875nvve:FiveCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-09-300001836875nvve:FiveCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-12-310001836875nvve:EngineeringServicesMember2025-07-012025-09-300001836875nvve:EngineeringServicesMember2024-07-012024-09-300001836875nvve:EngineeringServicesMember2025-01-012025-09-300001836875nvve:EngineeringServicesMember2024-01-012024-09-300001836875nvve:GridServicesMember2025-07-012025-09-300001836875nvve:GridServicesMember2024-07-012024-09-300001836875nvve:GridServicesMember2025-01-012025-09-300001836875nvve:GridServicesMember2024-01-012024-09-300001836875nvve:EngineeringServicesManagementFeesMember2025-01-012025-09-3000018368752025-10-012025-09-3000018368752026-01-012025-09-3000018368752027-01-012025-09-3000018368752028-01-012025-09-3000018368752029-01-012025-09-300001836875country:US2025-07-012025-09-300001836875country:US2024-07-012024-09-300001836875country:US2025-01-012025-09-300001836875country:US2024-01-012024-09-300001836875country:DK2025-07-012025-09-300001836875country:DK2024-07-012024-09-300001836875country:DK2025-01-012025-09-300001836875country:DK2024-01-012024-09-300001836875nvve:February2024WarrantsMemberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:February2024WarrantsMemberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:February2024WarrantsMemberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:February2024WarrantsMember2025-09-300001836875nvve:February2024WarrantsMember2025-07-012025-09-300001836875nvve:February2024WarrantsMember2025-01-012025-09-300001836875nvve:October2024WarrantsMemberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:October2024WarrantsMemberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:October2024WarrantsMemberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:October2024WarrantsMember2025-09-300001836875nvve:October2024WarrantsMember2025-07-012025-09-300001836875nvve:October2024WarrantsMember2025-01-012025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Memberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Memberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Memberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-07-012025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-01-012025-09-300001836875nvve:October2024AdditionalInvestmentRightsMemberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:October2024AdditionalInvestmentRightsMemberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:October2024AdditionalInvestmentRightsMemberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:October2024AdditionalInvestmentRightsMember2025-09-300001836875nvve:October2024AdditionalInvestmentRightsMember2025-07-012025-09-300001836875nvve:October2024AdditionalInvestmentRightsMember2025-01-012025-09-300001836875nvve:December2024WarrantsMemberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:December2024WarrantsMemberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:December2024WarrantsMemberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:December2024WarrantsMember2025-09-300001836875nvve:December2024WarrantsMember2025-07-012025-09-300001836875nvve:December2024WarrantsMember2025-01-012025-09-300001836875nvve:WarrantsIssuedOnMarch52025Memberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:WarrantsIssuedOnMarch52025Memberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:WarrantsIssuedOnMarch52025Memberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:WarrantsIssuedOnMarch52025Member2025-09-300001836875nvve:WarrantsIssuedOnMarch52025Member2025-07-012025-09-300001836875nvve:WarrantsIssuedOnMarch52025Member2025-01-012025-09-300001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMemberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMemberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMemberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMemberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMemberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMemberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Memberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Memberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Memberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-07-012025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-01-012025-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMemberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMemberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMemberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Memberus-gaap:FairValueInputsLevel1Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Memberus-gaap:FairValueInputsLevel2Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Memberus-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-07-012025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-01-012025-09-300001836875us-gaap:FairValueInputsLevel1Member2025-09-300001836875us-gaap:FairValueInputsLevel2Member2025-09-300001836875us-gaap:FairValueInputsLevel3Member2025-09-300001836875nvve:July2022WarrantsMemberus-gaap:FairValueInputsLevel1Member2024-12-310001836875nvve:July2022WarrantsMemberus-gaap:FairValueInputsLevel2Member2024-12-310001836875nvve:July2022WarrantsMemberus-gaap:FairValueInputsLevel3Member2024-12-310001836875nvve:July2022WarrantsMember2024-12-310001836875nvve:July2022WarrantsMember2024-07-012024-09-300001836875nvve:July2022WarrantsMember2024-01-012024-09-300001836875nvve:PrivateWarrantsJuly2024Memberus-gaap:FairValueInputsLevel1Member2024-12-310001836875nvve:PrivateWarrantsJuly2024Memberus-gaap:FairValueInputsLevel2Member2024-12-310001836875nvve:PrivateWarrantsJuly2024Memberus-gaap:FairValueInputsLevel3Member2024-12-310001836875nvve:PrivateWarrantsJuly2024Member2024-12-310001836875nvve:PrivateWarrantsJuly2024Member2024-07-012024-09-300001836875nvve:PrivateWarrantsJuly2024Member2024-01-012024-09-300001836875nvve:February2024WarrantsMemberus-gaap:FairValueInputsLevel1Member2024-12-310001836875nvve:February2024WarrantsMemberus-gaap:FairValueInputsLevel2Member2024-12-310001836875nvve:February2024WarrantsMemberus-gaap:FairValueInputsLevel3Member2024-12-310001836875nvve:February2024WarrantsMember2024-12-310001836875nvve:February2024WarrantsMember2024-07-012024-09-300001836875nvve:February2024WarrantsMember2024-01-012024-09-300001836875nvve:October2024WarrantsMemberus-gaap:FairValueInputsLevel1Member2024-12-310001836875nvve:October2024WarrantsMemberus-gaap:FairValueInputsLevel2Member2024-12-310001836875nvve:October2024WarrantsMemberus-gaap:FairValueInputsLevel3Member2024-12-310001836875nvve:October2024WarrantsMember2024-12-310001836875nvve:October2024WarrantsMember2024-07-012024-09-300001836875nvve:October2024WarrantsMember2024-01-012024-09-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Memberus-gaap:FairValueInputsLevel1Member2024-12-310001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Memberus-gaap:FairValueInputsLevel2Member2024-12-310001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Memberus-gaap:FairValueInputsLevel3Member2024-12-310001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Member2024-12-310001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Member2024-07-012024-09-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Member2024-01-012024-09-300001836875nvve:October2024AdditionalInvestmentRightsMemberus-gaap:FairValueInputsLevel1Member2024-12-310001836875nvve:October2024AdditionalInvestmentRightsMemberus-gaap:FairValueInputsLevel2Member2024-12-310001836875nvve:October2024AdditionalInvestmentRightsMemberus-gaap:FairValueInputsLevel3Member2024-12-310001836875nvve:October2024AdditionalInvestmentRightsMember2024-12-310001836875nvve:October2024AdditionalInvestmentRightsMember2024-07-012024-09-300001836875nvve:October2024AdditionalInvestmentRightsMember2024-01-012024-09-300001836875nvve:December2024WarrantsMemberus-gaap:FairValueInputsLevel1Member2024-12-310001836875nvve:December2024WarrantsMemberus-gaap:FairValueInputsLevel2Member2024-12-310001836875nvve:December2024WarrantsMemberus-gaap:FairValueInputsLevel3Member2024-12-310001836875nvve:December2024WarrantsMember2024-12-310001836875nvve:December2024WarrantsMember2024-07-012024-09-300001836875nvve:December2024WarrantsMember2024-01-012024-09-300001836875us-gaap:RedeemablePreferredStockMemberus-gaap:FairValueInputsLevel1Member2024-12-310001836875us-gaap:RedeemablePreferredStockMemberus-gaap:FairValueInputsLevel2Member2024-12-310001836875us-gaap:RedeemablePreferredStockMemberus-gaap:FairValueInputsLevel3Member2024-12-310001836875us-gaap:RedeemablePreferredStockMember2024-12-310001836875us-gaap:RedeemablePreferredStockMember2024-07-012024-09-300001836875us-gaap:RedeemablePreferredStockMember2024-01-012024-09-300001836875us-gaap:FairValueInputsLevel1Member2024-12-310001836875us-gaap:FairValueInputsLevel2Member2024-12-310001836875us-gaap:FairValueInputsLevel3Member2024-12-310001836875nvve:WarrantsIssuedOnMarch52025Member2024-12-310001836875nvve:SeniorConvertibleNotesIssuedOnMarch312025Member2024-12-310001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMember2024-12-310001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMember2024-12-310001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Member2024-12-310001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2024-12-310001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2024-12-310001836875nvve:February2024WarrantsMember2025-01-012025-03-310001836875nvve:October2024WarrantsMember2025-01-012025-03-310001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-01-012025-03-310001836875nvve:October2024AdditionalInvestmentRightsMember2025-01-012025-03-310001836875nvve:December2024WarrantsMember2025-01-012025-03-310001836875nvve:WarrantsIssuedOnMarch52025Member2025-01-012025-03-310001836875nvve:SeniorConvertibleNotesIssuedOnMarch312025Member2025-01-012025-03-310001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-03-310001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-03-310001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-01-012025-03-310001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-03-310001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-01-012025-03-310001836875nvve:February2024WarrantsMember2025-03-310001836875nvve:October2024WarrantsMember2025-03-310001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-03-310001836875nvve:October2024AdditionalInvestmentRightsMember2025-03-310001836875nvve:December2024WarrantsMember2025-03-310001836875nvve:WarrantsIssuedOnMarch52025Member2025-03-310001836875nvve:SeniorConvertibleNotesIssuedOnMarch312025Member2025-03-310001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-03-310001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-03-310001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-03-310001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-03-310001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-03-310001836875nvve:February2024WarrantsMember2025-04-012025-06-300001836875nvve:October2024WarrantsMember2025-04-012025-06-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-04-012025-06-300001836875nvve:October2024AdditionalInvestmentRightsMember2025-04-012025-06-300001836875nvve:December2024WarrantsMember2025-04-012025-06-300001836875nvve:WarrantsIssuedOnMarch52025Member2025-04-012025-06-300001836875nvve:SeniorConvertibleNotesIssuedOnMarch312025Member2025-04-012025-06-300001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-04-012025-06-300001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-04-012025-06-300001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-04-012025-06-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-04-012025-06-300001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-04-012025-06-300001836875nvve:February2024WarrantsMember2025-06-300001836875nvve:October2024WarrantsMember2025-06-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-06-300001836875nvve:October2024AdditionalInvestmentRightsMember2025-06-300001836875nvve:December2024WarrantsMember2025-06-300001836875nvve:WarrantsIssuedOnMarch52025Member2025-06-300001836875nvve:SeniorConvertibleNotesIssuedOnMarch312025Member2025-06-300001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-06-300001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-06-300001836875nvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-06-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-06-300001836875nvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-06-300001836875nvve:SeniorConvertibleNotesIssuedOnMarch312025Member2025-07-012025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnMarch312025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:July2022WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:July2022WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:July2022WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:July2022WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:July2022WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:February2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:February2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:February2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:February2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:February2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:February2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:February2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:February2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:February2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:February2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:October2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:October2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:October2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:October2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:October2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:October2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:October2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:October2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:October2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:October2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:SeniorConvertibleNotesIssuedOnOctober312024Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:SeniorConvertibleNotesIssuedOnOctober312024Member2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:SeniorConvertibleNotesIssuedOnOctober312024Member2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:SeniorConvertibleNotesIssuedOnOctober312024Member2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:SeniorConvertibleNotesIssuedOnOctober312024Member2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:SeniorConvertibleNotesIssuedOnOctober312024Member2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:October2024AdditionalInvestmentRightsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:October2024AdditionalInvestmentRightsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:October2024AdditionalInvestmentRightsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:October2024AdditionalInvestmentRightsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:October2024AdditionalInvestmentRightsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:October2024AdditionalInvestmentRightsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:October2024AdditionalInvestmentRightsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:October2024AdditionalInvestmentRightsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:October2024AdditionalInvestmentRightsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:October2024AdditionalInvestmentRightsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:December2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:December2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:December2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:December2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:December2024WarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:December2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:December2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:December2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:December2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:December2024WarrantsMember2024-12-310001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:WarrantsIssuedOnMarch52025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:WarrantsIssuedOnMarch52025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:WarrantsIssuedOnMarch52025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:WarrantsIssuedOnMarch52025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:WarrantsIssuedOnMarch52025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMembernvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:SeniorConvertibleNotesIssuedOnMay302025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Membernvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembernvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMembernvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-09-300001836875us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMembernvve:SeniorConvertibleNotesIssuedOnSeptember302025Member2025-09-300001836875nvve:TermLoanMember2025-09-300001836875nvve:TermLoanMember2024-12-310001836875nvve:PromissoryNotesIssuedOnAugust162024Member2025-09-300001836875nvve:PromissoryNotesIssuedOnAugust162024Member2024-12-310001836875nvve:PromissoryNotesIssuedOnAugust272024Member2025-09-300001836875nvve:PromissoryNotesIssuedOnAugust272024Member2024-12-310001836875nvve:SeniorConvertibleNotesIssuedOnDecember312024Member2025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnDecember312024Member2024-12-310001836875nvve:PromissoryNotesFermataEnergyIILLCMember2025-09-300001836875nvve:PromissoryNotesFermataEnergyIILLCMember2024-12-310001836875nvve:DreevMember2025-09-300001836875nvve:DreevMemberus-gaap:SubsequentEventMember2025-10-080001836875nvve:DreevMemberus-gaap:SubsequentEventMember2025-10-082025-10-080001836875us-gaap:TradeAccountsReceivableMember2025-09-300001836875us-gaap:TradeAccountsReceivableMember2024-12-310001836875nvve:DCChargersMember2025-09-300001836875nvve:DCChargersMember2024-12-310001836875nvve:ACChargersMember2025-09-300001836875nvve:ACChargersMember2024-12-310001836875nvve:ComponentPartsAndCarbonCreditMember2025-09-300001836875nvve:ComponentPartsAndCarbonCreditMember2024-12-310001836875srt:MinimumMemberus-gaap:ComputerEquipmentMember2025-09-300001836875srt:MaximumMemberus-gaap:ComputerEquipmentMember2025-09-300001836875us-gaap:ComputerEquipmentMember2025-09-300001836875us-gaap:ComputerEquipmentMember2024-12-310001836875srt:MinimumMemberus-gaap:VehiclesMember2025-09-300001836875srt:MaximumMemberus-gaap:VehiclesMember2025-09-300001836875us-gaap:VehiclesMember2025-09-300001836875us-gaap:VehiclesMember2024-12-310001836875srt:MinimumMemberus-gaap:OfficeEquipmentMember2025-09-300001836875srt:MaximumMemberus-gaap:OfficeEquipmentMember2025-09-300001836875us-gaap:OfficeEquipmentMember2025-09-300001836875us-gaap:OfficeEquipmentMember2024-12-310001836875srt:MinimumMembernvve:TestUnitsAndLoanedChargersMember2025-09-300001836875srt:MaximumMembernvve:TestUnitsAndLoanedChargersMember2025-09-300001836875nvve:TestUnitsAndLoanedChargersMember2025-09-300001836875nvve:TestUnitsAndLoanedChargersMember2024-12-310001836875nvve:SeniorConvertibleNotesOctober2024Member2025-09-300001836875nvve:SeniorConvertibleNotesOctober2024Member2024-12-310001836875nvve:SeniorConvertibleNotesMay2025Member2025-09-300001836875nvve:SeniorConvertibleNotesMay2025Member2024-12-310001836875nvve:SeniorConvertibleNotesSeptember2025Member2025-09-300001836875nvve:SeniorConvertibleNotesSeptember2025Member2024-12-310001836875nvve:August2024TermLoanMemberus-gaap:SubordinatedDebtMember2025-09-300001836875nvve:November2024TermLoanMemberus-gaap:SubordinatedDebtMember2025-09-300001836875nvve:March2025TermLoanMemberus-gaap:SubordinatedDebtMember2025-09-300001836875nvve:TermLoanMember2025-07-012025-09-300001836875nvve:TermLoanMember2025-01-012025-09-300001836875nvve:TermLoanMember2024-07-012024-09-300001836875nvve:TermLoanMember2024-01-012024-09-300001836875nvve:PromissoryNotesIssuedOnAugust162024Membernvve:ChiefExecutiveOfficerAndChiefFinancialOfficerMembernvve:PromissoryNotesMember2024-08-160001836875nvve:PromissoryNotesIssuedOnAugust162024Membernvve:PromissoryNotesMember2024-08-160001836875nvve:PromissoryNotesIssuedOnAugust162024Membersrt:ChiefExecutiveOfficerMembernvve:PromissoryNotesMember2025-09-300001836875nvve:PromissoryNotesIssuedOnAugust162024Membersrt:ChiefFinancialOfficerMembernvve:PromissoryNotesMember2025-09-300001836875nvve:PromissoryNotesIssuedOnAugust162024Membernvve:PromissoryNotesMember2024-08-162024-08-160001836875nvve:PromissoryNotesIssuedOnAugust162024Membernvve:PromissoryNotesMember2025-07-012025-09-300001836875nvve:PromissoryNotesIssuedOnAugust162024Membernvve:PromissoryNotesMember2025-01-012025-09-300001836875nvve:PromissoryNotesIssuedOnAugust162024Membernvve:PromissoryNotesMember2024-01-012024-09-300001836875nvve:PromissoryNotesIssuedOnAugust162024Membernvve:PromissoryNotesMember2024-07-012024-09-300001836875nvve:PromissoryNotesIssuedFebruary2025Membernvve:PromissoryNotesMember2025-02-280001836875nvve:PromissoryNotesIssuedFebruary2025Membersrt:ChiefExecutiveOfficerMembernvve:PromissoryNotesMember2025-02-280001836875nvve:PromissoryNotesIssuedFebruary2025Membersrt:ChiefFinancialOfficerMembernvve:PromissoryNotesMember2025-02-280001836875nvve:PromissoryNotesIssuedFebruary2025Membernvve:PromissoryNotesMember2025-02-012025-02-280001836875nvve:PromissoryNotesIssuedFebruary2025Membernvve:PromissoryNotesMember2025-07-012025-09-300001836875nvve:PromissoryNotesIssuedFebruary2025Membernvve:PromissoryNotesMember2025-01-012025-09-300001836875nvve:PromissoryNotesIssuedFebruary2025Membernvve:PromissoryNotesMember2025-09-242025-09-240001836875nvve:PromissoryNotesIssuedOnAugust272024Membernvve:ChiefExecutiveOfficerAndChiefFinancialOfficerMembernvve:PromissoryNotesMember2024-08-270001836875nvve:PromissoryNotesIssuedOnAugust272024Membernvve:PromissoryNotesMember2024-08-270001836875nvve:PromissoryNotesIssuedOnAugust272024Membernvve:ChiefExecutiveOfficerAndChiefFinancialOfficerMember2024-08-272024-08-270001836875nvve:PromissoryNotesIssuedOnAugust272024Membersrt:MinimumMembernvve:PromissoryNotesMember2024-08-270001836875nvve:PromissoryNotesIssuedOnAugust272024Membersrt:MaximumMembernvve:PromissoryNotesMember2024-08-270001836875nvve:PromissoryNotesIssuedOnAugust272024Membernvve:PromissoryNotesMember2025-01-012025-09-300001836875nvve:PromissoryNotesIssuedOnAugust272024Membernvve:PromissoryNotesMember2025-07-012025-09-300001836875nvve:PromissoryNotesIssuedOnAugust272024Membernvve:PromissoryNotesMember2024-07-012024-09-300001836875nvve:PromissoryNotesIssuedOnAugust272024Membernvve:PromissoryNotesMember2024-01-012024-09-300001836875nvve:PromissoryNotesIssuedOnAugust272024Membernvve:PromissoryNotesMember2025-01-312025-01-310001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Memberus-gaap:ConvertibleDebtMember2024-10-310001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Membersrt:ChiefExecutiveOfficerMemberus-gaap:ConvertibleDebtMember2024-10-310001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Memberus-gaap:ConvertibleDebtMember2024-10-012024-10-310001836875nvve:WarrantsIssuedOctober312024Member2024-10-310001836875us-gaap:ConvertibleDebtMember2024-10-310001836875us-gaap:ConvertibleDebtMember2024-10-012024-10-310001836875nvve:AdditionalNotesAndWarrantsIssuedOctober312024Memberus-gaap:ConvertibleDebtMember2024-10-012024-10-310001836875nvve:SeniorConvertibleNotesOctober2024Membernvve:PromissoryNotesMember2025-07-012025-09-300001836875nvve:SeniorConvertibleNotesOctober2024Membernvve:PromissoryNotesMember2025-01-012025-09-300001836875nvve:SeniorConvertibleNotesOctober2024Membernvve:PromissoryNotesMember2024-07-012024-09-300001836875nvve:SeniorConvertibleNotesOctober2024Membernvve:PromissoryNotesMember2024-01-012024-09-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Memberus-gaap:ConvertibleDebtMember2025-01-012025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnOctober312024Memberus-gaap:ConvertibleDebtMember2025-09-300001836875nvve:October2024WarrantsMember2025-01-012025-09-300001836875nvve:October2024WarrantsMember2025-09-300001836875nvve:December2024TermLoanMemberus-gaap:ConvertibleDebtMember2024-12-310001836875nvve:December2024TermLoanMemberus-gaap:ConvertibleDebtMember2024-12-012024-12-310001836875nvve:WarrantsIssuedDecember312024Member2024-12-310001836875nvve:SeniorConvertibleNotesIssuedOnDecember312024Memberus-gaap:ConvertibleDebtMember2025-07-012025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnDecember312024Memberus-gaap:ConvertibleDebtMember2025-01-012025-09-300001836875nvve:SeniorConvertibleNotesIssuedOnDecember312024Memberus-gaap:ConvertibleDebtMember2024-01-012024-09-300001836875nvve:SeniorConvertibleNotesIssuedOnDecember312024Memberus-gaap:ConvertibleDebtMember2024-07-012024-09-300001836875nvve:SeniorConvertibleNotesIssuedOnDecember312024Memberus-gaap:ConvertibleDebtMember2025-09-300001836875nvve:SeniorConvertibleNotesMarch2025Memberus-gaap:ConvertibleDebtMember2025-03-050001836875nvve:SeniorConvertibleNotesMarch2025Memberus-gaap:ConvertibleDebtMember2025-03-052025-03-050001836875nvve:WarrantsIssuedOnMarch52025Member2025-03-0500018368752025-03-050001836875nvve:SeniorConvertibleNotesMarch2025Memberus-gaap:ConvertibleDebtMember2025-07-012025-09-300001836875nvve:SeniorConvertibleNotesMarch2025Memberus-gaap:ConvertibleDebtMember2025-01-012025-09-300001836875nvve:SeniorConvertibleNotesMarch2025Memberus-gaap:ConvertibleDebtMember2024-01-012024-09-300001836875nvve:SeniorConvertibleNotesMarch2025Memberus-gaap:ConvertibleDebtMember2024-07-012024-09-300001836875nvve:SeniorConvertibleNotesMarch2025Memberus-gaap:ConvertibleDebtMember2025-09-300001836875nvve:March2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:March2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:SeniorConvertibleNotesApril2025Memberus-gaap:ConvertibleDebtMember2025-04-280001836875nvve:SeniorConvertibleNotesApril2025Memberus-gaap:ConvertibleDebtMember2025-04-282025-04-280001836875nvve:WarrantsIssuedOnApril282025Member2025-04-2800018368752025-04-280001836875nvve:SeniorConvertibleNotesApril2025Memberus-gaap:ConvertibleDebtMember2025-07-012025-09-300001836875nvve:SeniorConvertibleNotesApril2025Memberus-gaap:ConvertibleDebtMember2025-01-012025-09-300001836875nvve:SeniorConvertibleNotesApril2025Memberus-gaap:ConvertibleDebtMember2024-07-012024-09-300001836875nvve:SeniorConvertibleNotesApril2025Memberus-gaap:ConvertibleDebtMember2024-01-012024-09-300001836875nvve:SeniorConvertibleNotesApril2025Memberus-gaap:ConvertibleDebtMember2025-09-300001836875nvve:A2025AprilInstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:A2025AprilInstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:SeniorConvertibleNotesMay2025Memberus-gaap:ConvertibleDebtMember2025-05-300001836875nvve:SeniorConvertibleNotesMay2025Memberus-gaap:ConvertibleDebtMember2025-05-302025-05-300001836875nvve:WarrantsIssuedOnMay302025Member2025-05-3000018368752025-05-300001836875nvve:SeniorConvertibleNotesMay2025Memberus-gaap:ConvertibleDebtMember2025-07-012025-09-300001836875nvve:SeniorConvertibleNotesMay2025Memberus-gaap:ConvertibleDebtMember2025-01-012025-09-300001836875nvve:SeniorConvertibleNotesMay2025Memberus-gaap:ConvertibleDebtMember2024-01-012024-09-300001836875nvve:SeniorConvertibleNotesMay2025Memberus-gaap:ConvertibleDebtMember2024-07-012024-09-300001836875nvve:SeniorConvertibleNotesMay2025Memberus-gaap:ConvertibleDebtMember2025-09-300001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:May2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:SeniorConvertibleNotesSeptember2025Memberus-gaap:ConvertibleDebtMember2025-09-100001836875nvve:SeniorConvertibleNotesSeptember2025Memberus-gaap:ConvertibleDebtMember2025-09-102025-09-100001836875nvve:WarrantsIssuedOnMay302025Member2025-09-1000018368752025-09-100001836875nvve:SeniorConvertibleNotesSeptember2025Memberus-gaap:ConvertibleDebtMember2025-07-012025-09-300001836875nvve:SeniorConvertibleNotesSeptember2025Memberus-gaap:ConvertibleDebtMember2025-01-012025-09-300001836875nvve:PromissoryNotesFermataEnergyIILLCMembernvve:PromissoryNotesMember2025-04-230001836875nvve:PromissoryNotesFermataEnergyIILLCMembernvve:PromissoryNotesMember2025-04-232025-04-230001836875nvve:PromissoryNotesFermataEnergyIILLCMembernvve:PromissoryNotesMember2025-07-012025-09-300001836875nvve:PromissoryNotesFermataEnergyIILLCMembernvve:PromissoryNotesMember2025-01-012025-09-300001836875nvve:PromissoryNotesFermataEnergyIILLCMembernvve:PromissoryNotesMember2024-01-012024-09-300001836875nvve:PromissoryNotesFermataEnergyIILLCMembernvve:PromissoryNotesMember2024-07-012024-09-3000018368752025-02-2000018368752025-02-210001836875nvve:UnderwritingAgreementMember2025-07-112025-07-110001836875nvve:PreFundedWarrantsMember2025-07-110001836875nvve:UnderwritingAgreementMember2025-07-110001836875nvve:UnderwriterWarrantsMembernvve:UnderwritingAgreementMember2025-07-110001836875nvve:UnderwritingAgreementMember2025-07-142025-07-140001836875nvve:RepresentativesWarrantMembernvve:UnderwritingAgreementMember2025-07-140001836875nvve:UnderwritingAgreementMember2024-02-022024-02-020001836875nvve:UnderwritingAgreementMemberus-gaap:CommonStockMember2024-02-022024-02-020001836875nvve:UnderwritingAgreementMemberus-gaap:CommonStockMember2024-01-312024-01-310001836875nvve:PreFundedWarrantsMembernvve:UnderwritingAgreementMemberus-gaap:WarrantMember2024-01-312024-01-310001836875nvve:SeriesAWarrantsMembernvve:UnderwritingAgreementMemberus-gaap:WarrantMember2024-01-312024-01-310001836875nvve:SeriesAWarrantsMembernvve:UnderwritingAgreementMemberus-gaap:WarrantMember2024-01-310001836875nvve:SeriesBWarrantsMembernvve:UnderwritingAgreementMemberus-gaap:WarrantMember2024-01-312024-01-310001836875nvve:SeriesBWarrantsMembernvve:UnderwritingAgreementMemberus-gaap:WarrantMember2024-01-310001836875nvve:SeriesCWarrantsMembernvve:UnderwritingAgreementMemberus-gaap:WarrantMember2024-01-312024-01-310001836875nvve:SeriesCWarrantsMembernvve:UnderwritingAgreementMemberus-gaap:WarrantMember2024-01-310001836875nvve:UnderwritingAgreementMember2024-01-310001836875nvve:UnderwritingAgreementMember2024-01-312024-01-310001836875nvve:PreFundedWarrantsMembernvve:UnderwritingAgreementMemberus-gaap:WarrantMember2024-01-310001836875nvve:UnderwriterWarrantsMembernvve:UnderwritingAgreementMember2024-01-310001836875nvve:UnderwriterWarrantsMembernvve:UnderwritingAgreementMember2024-01-312024-01-310001836875us-gaap:WarrantMember2020-02-192020-02-190001836875nvve:NewbornAcquisitionCorpMemberus-gaap:IPOMember2020-02-192020-02-190001836875us-gaap:PrivatePlacementMemberus-gaap:WarrantMember2020-02-192020-02-190001836875nvve:NewbornAcquisitionCorpMemberus-gaap:PrivatePlacementMember2020-02-192020-02-190001836875us-gaap:InvestorMember2020-11-112020-11-110001836875nvve:NewbornAcquisitionCorpMemberus-gaap:InvestorMember2020-11-110001836875nvve:NewbornAcquisitionCorpMembernvve:PIPEMember2020-11-112020-11-110001836875nvve:PIPEWarrantsMember2020-11-112020-11-110001836875nvve:PIPEWarrantsMember2020-11-110001836875nvve:PrivateWarrantsMay2025Member2025-05-310001836875nvve:PrivateWarrantsMay2025Member2025-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:March2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:December2024InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:October2024InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:April2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:March2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:December2024InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:October2024InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:PublicWarrantsMember2025-01-012025-09-300001836875nvve:PublicWarrantsMember2025-09-300001836875nvve:PrivateWarrantsFebruary2020Member2025-01-012025-09-300001836875nvve:PrivateWarrantsFebruary2020Member2025-09-300001836875nvve:PIPEWarrantsMember2025-01-012025-09-300001836875nvve:PIPEWarrantsMember2025-09-300001836875nvve:July2022InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:July2022InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:UnderwriterWarrantsFebruary2024OfferingMember2025-01-012025-09-300001836875nvve:UnderwriterWarrantsFebruary2024OfferingMember2025-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesAMember2025-01-012025-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesAMember2025-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesCMember2025-01-012025-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesCMember2025-09-300001836875nvve:July2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:July2025InstitutionalAccreditedInvestorWarrantsMember2025-09-300001836875nvve:May2025ConsultingWarrants1stTrancheMember2025-01-012025-09-300001836875nvve:May2025ConsultingWarrants1stTrancheMember2025-09-300001836875nvve:May2025ConsultingWarrants2ndTrancheMember2025-01-012025-09-300001836875nvve:May2025ConsultingWarrants2ndTrancheMember2025-09-300001836875nvve:May2025ConsultingWarrants3rdTrancheMember2025-01-012025-09-300001836875nvve:May2025ConsultingWarrants3rdTrancheMember2025-09-300001836875nvve:May2025ConsultingWarrants4thTrancheMember2025-01-012025-09-300001836875nvve:May2025ConsultingWarrants4thTrancheMember2025-09-300001836875nvve:May2025ConsultingWarrants5thTrancheMember2025-01-012025-09-300001836875nvve:May2025ConsultingWarrants5thTrancheMember2025-09-300001836875nvve:May2025ConsultingWarrants6thTrancheMember2025-01-012025-09-300001836875nvve:May2025ConsultingWarrants6thTrancheMember2025-09-300001836875nvve:UnitPurchaseOptionMember2020-02-190001836875nvve:NewbornAcquisitionCorpMemberus-gaap:IPOMember2020-02-192020-02-190001836875nvve:NewbornAcquisitionCorpMemberus-gaap:IPOMember2020-02-190001836875srt:MinimumMembernvve:UnitPurchaseOptionMember2020-02-190001836875srt:MaximumMembernvve:UnitPurchaseOptionMember2020-02-190001836875nvve:FermataEnergyIILLCMemberus-gaap:PreferredClassAMember2025-04-3000018368752024-09-172024-09-170001836875nvve:A2020PlanMember2025-08-012025-08-310001836875nvve:A2020PlanMember2025-09-300001836875nvve:A2020PlanMember2025-01-012025-09-300001836875nvve:A2020PlanMemberus-gaap:EmployeeStockOptionMember2025-01-012025-09-300001836875nvve:A2020PlanMemberus-gaap:SubsequentEventMember2025-11-080001836875us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockOptionMember2025-07-012025-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockOptionMember2024-07-012024-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockOptionMember2025-01-012025-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockOptionMember2024-01-012024-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockMember2025-07-012025-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockMember2024-07-012024-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockMember2025-01-012025-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockMember2024-01-012024-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMembernvve:StockOptionsModifiedOptionsMember2025-07-012025-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMembernvve:StockOptionsModifiedOptionsMember2024-07-012024-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMembernvve:StockOptionsModifiedOptionsMember2025-01-012025-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMembernvve:StockOptionsModifiedOptionsMember2024-01-012024-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMembernvve:ProfitInterestUnitsMember2025-07-012025-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMembernvve:ProfitInterestUnitsMember2024-07-012024-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMembernvve:ProfitInterestUnitsMember2025-01-012025-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMembernvve:ProfitInterestUnitsMember2024-01-012024-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-07-012025-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-09-300001836875us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-09-300001836875nvve:A2010PlanMember2024-12-310001836875nvve:A2010PlanMember2024-01-012024-12-310001836875nvve:A2010PlanMember2025-01-012025-09-300001836875nvve:A2010PlanMember2025-09-300001836875nvve:A2020PlanMember2024-12-310001836875nvve:A2020PlanMember2024-01-012024-12-3100018368752021-01-012021-12-310001836875us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001836875us-gaap:EmployeeStockOptionMember2024-07-012024-09-300001836875us-gaap:RestrictedStockUnitsRSUMember2025-09-300001836875us-gaap:RestrictedStockUnitsRSUMember2024-12-310001836875us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-09-300001836875us-gaap:RestrictedStockMember2025-09-300001836875nvve:StockOptionsMember2025-07-012025-09-300001836875nvve:StockOptionsMember2024-07-012024-09-300001836875nvve:StockOptionsMember2025-01-012025-09-300001836875nvve:StockOptionsMember2024-01-012024-09-300001836875nvve:NonvestedRestrictedStockMember2025-07-012025-09-300001836875nvve:NonvestedRestrictedStockMember2024-07-012024-09-300001836875nvve:NonvestedRestrictedStockMember2025-01-012025-09-300001836875nvve:NonvestedRestrictedStockMember2024-01-012024-09-300001836875nvve:PublicWarrantsMember2025-07-012025-09-300001836875nvve:PublicWarrantsMember2024-07-012024-09-300001836875nvve:PublicWarrantsMember2025-01-012025-09-300001836875nvve:PublicWarrantsMember2024-01-012024-09-300001836875nvve:PrivateWarrantsFebruary2020Member2025-07-012025-09-300001836875nvve:PrivateWarrantsFebruary2020Member2024-07-012024-09-300001836875nvve:PrivateWarrantsFebruary2020Member2025-01-012025-09-300001836875nvve:PrivateWarrantsFebruary2020Member2024-01-012024-09-300001836875nvve:PrivatePreFundedWarrantsJuly2024Member2025-07-012025-09-300001836875nvve:PrivatePreFundedWarrantsJuly2024Member2024-07-012024-09-300001836875nvve:PrivatePreFundedWarrantsJuly2024Member2025-01-012025-09-300001836875nvve:PrivatePreFundedWarrantsJuly2024Member2024-01-012024-09-300001836875nvve:PIPEWarrantsMember2025-07-012025-09-300001836875nvve:PIPEWarrantsMember2024-07-012024-09-300001836875nvve:PIPEWarrantsMember2025-01-012025-09-300001836875nvve:PIPEWarrantsMember2024-01-012024-09-300001836875nvve:July2022InstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:July2022InstitutionalAccreditedInvestorWarrantsMember2024-07-012024-09-300001836875nvve:July2022InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:July2022InstitutionalAccreditedInvestorWarrantsMember2024-01-012024-09-300001836875nvve:UnderwriterWarrantsFebruary2024OfferingMember2025-07-012025-09-300001836875nvve:UnderwriterWarrantsFebruary2024OfferingMember2024-07-012024-09-300001836875nvve:UnderwriterWarrantsFebruary2024OfferingMember2025-01-012025-09-300001836875nvve:UnderwriterWarrantsFebruary2024OfferingMember2024-01-012024-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesAMember2025-07-012025-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesAMember2024-07-012024-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesAMember2025-01-012025-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesAMember2024-01-012024-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesBMember2025-07-012025-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesBMember2024-07-012024-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesBMember2025-01-012025-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesBMember2024-01-012024-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesCMember2025-07-012025-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesCMember2024-07-012024-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesCMember2025-01-012025-09-300001836875nvve:February2024InstitutionalAccreditedInvestorWarrantsSeriesCMember2024-01-012024-09-300001836875nvve:October2024InstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:October2024InstitutionalAccreditedInvestorWarrantsMember2024-07-012024-09-300001836875nvve:October2024InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:October2024InstitutionalAccreditedInvestorWarrantsMember2024-01-012024-09-300001836875nvve:A2024DecemberInstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:A2024DecemberInstitutionalAccreditedInvestorWarrantsMember2024-07-012024-09-300001836875nvve:A2024DecemberInstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:A2024DecemberInstitutionalAccreditedInvestorWarrantsMember2024-01-012024-09-300001836875nvve:March2025InstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:March2025InstitutionalAccreditedInvestorWarrantsMember2024-07-012024-09-300001836875nvve:March2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:March2025InstitutionalAccreditedInvestorWarrantsMember2024-01-012024-09-300001836875nvve:A2025AprilInstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:A2025AprilInstitutionalAccreditedInvestorWarrantsMember2024-07-012024-09-300001836875nvve:A2025AprilInstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:A2025AprilInstitutionalAccreditedInvestorWarrantsMember2024-01-012024-09-300001836875nvve:A2025MayInstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:A2025MayInstitutionalAccreditedInvestorWarrantsMember2024-07-012024-09-300001836875nvve:A2025MayInstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:A2025MayInstitutionalAccreditedInvestorWarrantsMember2024-01-012024-09-300001836875nvve:July2025InstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:July2025InstitutionalAccreditedInvestorWarrantsMember2024-07-012024-09-300001836875nvve:July2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:July2025InstitutionalAccreditedInvestorWarrantsMember2024-01-012024-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-07-012025-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2024-07-012024-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2025-01-012025-09-300001836875nvve:September2025InstitutionalAccreditedInvestorWarrantsMember2024-01-012024-09-300001836875nvve:May2025ConsultingWarrants1stTrancheMember2025-07-012025-09-300001836875nvve:May2025ConsultingWarrants1stTrancheMember2024-07-012024-09-300001836875nvve:May2025ConsultingWarrants1stTrancheMember2025-01-012025-09-300001836875nvve:May2025ConsultingWarrants1stTrancheMember2024-01-012024-09-300001836875nvve:May2025ConsultingWarrants2ndTrancheMember2025-07-012025-09-300001836875nvve:May2025ConsultingWarrants2ndTrancheMember2024-07-012024-09-300001836875nvve:May2025ConsultingWarrants2ndTrancheMember2025-01-012025-09-300001836875nvve:May2025ConsultingWarrants2ndTrancheMember2024-01-012024-09-300001836875nvve:BoardMembersMember2025-09-300001836875us-gaap:RelatedPartyMember2025-07-012025-09-300001836875us-gaap:RelatedPartyMember2025-01-012025-09-300001836875us-gaap:RelatedPartyMember2024-07-012024-09-300001836875us-gaap:RelatedPartyMember2024-01-012024-09-300001836875nvve:SecuritiesPurchaseAgreementMembersrt:ChiefExecutiveOfficerMembernvve:PromissoryNotesMember2024-10-310001836875nvve:SeniorConvertibleNotesOctober2024Membersrt:ChiefExecutiveOfficerMembernvve:PromissoryNotesMember2024-10-310001836875nvve:SecuritiesPurchaseAgreementMembersrt:ChiefExecutiveOfficerMembernvve:PromissoryNotesMember2025-01-012025-09-300001836875nvve:SecuritiesPurchaseAgreementMembersrt:ChiefExecutiveOfficerMembernvve:PromissoryNotesMember2025-09-300001836875nvve:PromissoryNotesFermataEnergyIILLCMembernvve:PromissoryNotesMember2025-04-300001836875us-gaap:InterestExpenseMember2025-07-012025-09-300001836875us-gaap:InterestExpenseMember2024-07-012024-09-300001836875us-gaap:InterestExpenseMember2025-01-012025-09-300001836875us-gaap:InterestExpenseMember2024-01-012024-09-3000018368752022-04-300001836875srt:MinimumMember2022-04-012022-04-300001836875srt:MaximumMember2022-04-012022-04-300001836875us-gaap:OtherOperatingIncomeExpenseMember2025-07-012025-09-300001836875us-gaap:OtherOperatingIncomeExpenseMember2024-07-012024-09-300001836875us-gaap:OtherOperatingIncomeExpenseMember2025-01-012025-09-300001836875us-gaap:OtherOperatingIncomeExpenseMember2024-01-012024-09-300001836875nvve:MasterServicesAgreementMember2022-02-280001836875nvve:MasterServicesAgreementMember2024-07-012024-09-300001836875nvve:MasterServicesAgreementMember2024-01-012024-09-300001836875nvve:MasterServicesAgreementMember2025-07-012025-09-300001836875nvve:MasterServicesAgreementMember2025-01-012025-09-3000018368752016-09-010001836875nvve:IPAcquisitionAgreementMember2017-11-012017-11-3000018368752017-11-300001836875nvve:A10000AggregatedVehiclesMember2025-01-012025-09-300001836875nvve:A20000AggregatedVehiclesMember2025-01-012025-09-300001836875nvve:A40000AggregatedVehiclesMember2025-01-012025-09-300001836875nvve:A60000AggregatedVehiclesMember2025-01-012025-09-300001836875nvve:A80000AggregatedVehiclesMember2025-01-012025-09-300001836875nvve:A100000AggregatedVehiclesMember2025-01-012025-09-300001836875nvve:A200000AggregatedVehiclesMember2025-01-012025-09-300001836875nvve:A250000AggregatedVehiclesMember2025-01-012025-09-3000018368752021-07-2000018368752024-02-0200018368752024-02-022024-02-020001836875nvve:LevoLLCAMember2024-10-150001836875nvve:LevoMobilityLLCMember2024-12-310001836875nvve:LevoMobilityLLCMember2023-12-310001836875nvve:LevoMobilityLLCMember2025-01-012025-09-300001836875nvve:LevoMobilityLLCMember2024-01-012024-12-310001836875nvve:LevoMobilityLLCMember2025-09-300001836875nvve:LevoMobilityLLCMember2025-07-012025-09-300001836875nvve:LevoMobilityLLCMember2024-07-012024-09-300001836875nvve:LevoMobilityLLCMember2024-01-012024-09-300001836875nvve:ReportableSegmentMember2025-07-012025-09-300001836875nvve:ReportableSegmentMember2024-07-012024-09-300001836875nvve:ReportableSegmentMember2025-01-012025-09-300001836875nvve:ReportableSegmentMember2024-01-012024-09-300001836875country:US2025-09-300001836875country:US2024-12-310001836875country:GB2025-09-300001836875country:GB2024-12-310001836875country:DK2025-09-300001836875country:DK2024-12-310001836875nvve:FermataEnergyLLCMember2025-04-252025-04-250001836875nvve:FermataEnergyLLCMember2025-04-250001836875srt:RestatementAdjustmentMembernvve:FermataEnergyLLCMember2025-04-252025-04-250001836875nvve:SeniorConvertibleNotesMay2025Memberus-gaap:ConvertibleDebtMemberus-gaap:SubsequentEventMember2025-10-012025-11-130001836875nvve:SeniorConvertibleNotesMay2025Memberus-gaap:ConvertibleDebtMemberus-gaap:SubsequentEventMember2025-11-130001836875nvve:SeniorConvertibleNotesApril2025AndMay2025WarrantsMemberus-gaap:SubsequentEventMember2025-10-012025-11-130001836875nvve:SeniorConvertibleNotesApril2025AndMay2025WarrantsMemberus-gaap:SubsequentEventMember2025-11-130001836875srt:MinimumMembersrt:ScenarioForecastMember2025-10-012025-12-310001836875srt:MaximumMembersrt:ScenarioForecastMember2025-10-012025-12-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2025

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission file number: 001-40296

NUVVE HOLDING CORP.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

86-1617000

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

2488 Historic Decatur Road, Suite 230

San Diego,

California

92106

(Address of principal executive offices)

(Zip Code)

(619)

456-5161

(Registrant’s telephone number), including area code

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbols

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

NVVE

The Nasdaq Stock Market

Warrants to Purchase Common Stock

NVVEW

The Nasdaq Stock Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

xYes o No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

x Yes o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

o Yes x No

As of November 8, 2025, 33,566,009 shares of the issuer’s common stock, par value $0.0001 per share, were issued and outstanding.

NUVVE HOLDING CORP.

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2025

TABLE OF CONTENTS


PART I—FINANCIAL INFORMATION			1
	Item 1.	Interim Condensed Consolidated Financial Statements and Notes (Unaudited).	1
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	41
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	52
	Item 4.	Controls and Procedures.	52

PART II—OTHER INFORMATION			53
	Item 1.	Legal Proceedings.	53
	Item 1A.	Risk Factors.	53
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	55
	Item 3.	Defaults Upon Senior Securities.	55
	Item 4.	Mine Safety Disclosures.	55
	Item 5.	Other Information.	55
	Item 6.	Exhibits.	55

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q and other documents incorporated herein by reference contain forward-looking statements that are based on current expectations, estimates, forecasts and projections about us, our future performance, our financial condition, our products, our business strategy, our beliefs and our management’s assumptions. In addition, we, or others on our behalf, may make forward-looking statements in press releases or written statements, or in our communications and discussions with investors and analysts in the normal course of business through meetings, webcasts, phone calls and conference calls. These forward-looking statements can be identified by the use of words like “anticipates,” “estimates,” “projects,” “expects,” “plans,” “believes,” “intends,” “will,” “could,” “may,” “assumes” and other words of similar meaning. These statements are based on management’s beliefs, assumptions, estimates and observations of future events based on information available to our management at the time the statements are made and include any statements that do not relate to any historical or current fact. These statements are not guarantees of future performance and they involve certain risks, uncertainties and assumptions that are difficult to predict. Actual outcomes and results may differ materially from what is expressed, implied or forecast by our forward-looking statements due in part to the risks, uncertainties and assumptions described in Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, as well as those discussed elsewhere in this Quarterly Report on Form 10-Q and other factors described from time to time in our filings with the Securities and Exchange Commission (the “SEC”).

Factors that could cause actual results to differ materially from those in forward-looking statements include, risks related to the rollout of Nuvve's business and the timing of expected business milestones; Nuvve's dependence on widespread acceptance and adoption of electric vehicles and increased installation of charging stations; Nuvve's ability to maintain effective internal controls over financial reporting, including the remediation of identified material weaknesses in internal control over financial reporting relating to segregation of duties with respect to, and access controls to, its financial record keeping system, and Nuvve's accounting staffing levels; Nuvve's current dependence on sales of charging stations for most of its revenues; overall demand for electric vehicle charging and the potential for reduced demand if governmental rebates, tax credits and other financial incentives are reduced, modified or eliminated or governmental mandates to increase the use of electric vehicles or decrease the use of vehicles powered by fossil fuels, either directly or indirectly through mandated limits on carbon emissions, are reduced, modified or eliminated; potential adverse effects on Nuvve's backlog, revenue and gross margins if customers increasingly claim clean energy credits and, as a result, they are no longer available to be claimed by Nuvve; the effects of competition on Nuvve's future business; risks related to Nuvve's dependence on its intellectual property and the risk that Nuvve's technology could have undetected defects or errors; the risk that we conduct a portion of our operations through a joint venture exposes us to risks and uncertainties, many of which are outside of our control; changes in applicable laws or regulations; risks related to disruption of management time from ongoing business operations due to our joint ventures; risks relating to privacy and data protection laws, privacy or data breaches, or the loss of data; the possibility that Nuvve may be adversely affected by other economic, business, and/or competitive factors; risks related to changes in regulations applicable to our operations; risks related to our bitcoin treasury strategy; as well as other risks described in this Quarterly Report on Form 10-Q and other factors described from time to time in our filings with the SEC.

Given these risks and uncertainties, you should not rely on forward-looking statements as a prediction of actual results. Any or all of the forward-looking statements contained in this Quarterly Report on Form 10-Q and any other public statement made by us, including by our management, may turn out to be incorrect. We are including this cautionary note to make applicable and take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise, except as required under federal securities laws and the rules and regulations of the SEC.

PART I—FINANCIAL INFORMATION

Item 1. Interim Financial Statements

NUVVE HOLDING CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


	September 30, 2025		December 31, 2024
Assets
Current assets
Cash	$	939,415	$	371,497
Restricted cash	320,000		320,000
Accounts receivable, net	1,109,255		2,148,198
Inventories	4,255,117		4,591,902

Prepaid expenses	838,876		494,986
Deferred costs - current	1,034,958		417,290
Other current assets	1,055,065		931,244
Total current assets	9,552,686		9,275,117

Property and equipment, net	666,590		613,958
Intangible assets, net	1,103,048		1,062,766
Goodwill	96,000		—
Investment in equity securities	670,951		670,951
Investment in leases	98,896		101,415
Right-of-use operating lease assets	3,907,809		4,493,360
Deferred costs - noncurrent	594,558		564,558

Security deposit, long-term	64,943		15,687
Total assets	$	16,755,481	$	16,797,812

Liabilities and Equity

Current liabilities
Accounts payable	$	2,944,507	$	1,882,357

Accrued expenses	5,662,373		3,393,205
Deferred revenue - current	1,152,815		506,496
Debt - term loan	549,778		1,609,928
Due to related party - promissory notes - current	583,957		562,241
Convertible notes - current	1,060,489		2,475,162
Operating lease liabilities - current	864,139		914,800

Other liabilities	124,565		6,969

Total current liabilities	12,942,623		11,351,158

Operating lease liabilities - noncurrent	3,698,514		4,254,173
Due to related party - promissory notes - noncurrent	840,500		840,500

Deferred revenue - noncurrent	574,570		771,747
Warrants/investment rights liability	409,454		699,087

Other long-term liabilities	208,297		170,794
Total liabilities	18,673,958		18,087,459

Commitments and Contingencies



Stockholders’ equity
Preferred Class A units, zero par value, 4,900,000 shares authorized; 4,900,000 units issued and outstanding at September 30, 2025, and zero units issued and outstanding at December 31, 2024, respectively	166,698		—
Class B units, zero par value, 2,500,000 units authorized; 150,000 units issued and outstanding at September 30, 2025, and zero units issued and outstanding at December 31, 2024, respectively	150,000		—

Preferred stock, $0.0001 par value, 1,000,000 shares authorized; zero shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively	—		—

Common stock, $0.0001 par value, 200,000,000 shares authorized; 22,482,750 and 904,949 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively	8,565		6,408

Treasury stock, at cost, 1,680 shares outstanding at September 30, 2025 and December 31, 2024, respectively	—		—
Additional paid-in capital	188,584,935		164,285,336
Accumulated other comprehensive income	40,488		46,494
Accumulated deficit	(190,358,139)		(165,599,076)
Nuvve Holding Corp. stockholders’ deficit	(1,407,453)		(1,260,838)
Non-controlling interests	(511,024)		(28,809)
Total stockholders’ deficit	(1,918,477)		(1,289,647)
Total deficit	(1,918,477)		(1,289,647)
Total Liabilities and Equity	$	16,755,481	$	16,797,812

The accompanying notes are an integral part of these condensed consolidated financial statements.

NUVVE HOLDING CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Revenue
Products	$	947,561	$	543,834	$	1,655,017	$	1,389,495
Services	380,876		1,265,499		839,264		1,786,937
Grants	270,190		108,885		349,800		323,722
Total revenue	1,598,627		1,918,218		2,844,081		3,500,154
Operating expenses
Cost of products	735,730		409,390		1,277,069		1,002,964
Cost of services	31,246		508,697		182,216		1,027,282
Selling, general, and administrative	4,763,634		2,126,681		23,723,683		12,544,563
Research and development	1,179,288		710,291		3,156,223		3,773,435
Total operating expenses	6,709,898		3,755,059		28,339,191		18,348,244

Operating loss	(5,111,271)		(1,836,841)		(25,495,110)		(14,848,090)
Other income (expense)
Interest (expense) income, net	(477,482)		(242,468)		(1,720,316)		(222,720)

Change in fair value of convertible notes	(112,367)		—		(60,663)		—
Change in fair value of warrants/investment rights liability	232,717		329,990		673,899		2,642,424
Change in fair value of derivative liability	—		—		—		(3,626)
Other, net	674,188		99,476		1,360,912		104,417
Total other income (expense), net	317,056		186,998		253,832		2,520,495
Loss before taxes	(4,794,215)		(1,649,843)		(25,241,278)		(12,327,595)
Income tax expense	—		—		—		—
Net loss	$	(4,794,215)	$	(1,649,843)	$	(25,241,278)	$	(12,327,595)
Less: Net loss attributable to non-controlling interests	(286,955)		—		(482,215)		—
Net loss attributable to Nuvve Holding Corp.	$	(4,507,260)	$	(1,649,843)	$	(24,759,063)	$	(12,327,595)
Less: Preferred dividends on redeemable non-controlling interests	—		—		—		—
Less: Accretion on redeemable non-controlling interests preferred shares	—		—		—		—
Net loss attributable to Nuvve Holding Corp. common stockholders	$	(4,507,260)	$	(1,649,843)	$	(24,759,063)	$	(12,327,595)

Net loss per share attributable to Nuvve Holding Corp. common stockholders, basic and diluted	$	(0.24)	$	(2.47)	$	(2.76)	$	(21.72)

Weighted-average shares used in computing net loss per share attributable to Nuvve Holding Corp. common stockholders, basic and diluted	18,557,638		666,894		8,954,465		567,486

The accompanying notes are an integral part of these condensed consolidated financial statements.

NUVVE HOLDING CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)


	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024

Net loss	$	(4,794,215)	$	(1,649,843)	$	(25,241,278)	$	(12,327,595)
Other comprehensive (loss) income, net of taxes
Foreign currency translation adjustments, net of taxes	(13,393)		2,214		(6,006)		(19,530)
Total comprehensive loss	$	(4,807,608)	$	(1,647,629)	$	(25,247,284)	$	(12,347,125)
Less: Comprehensive loss attributable to non-controlling interests	(286,955)		—		(482,215)		—



Comprehensive loss attributable to Nuvve Holding Corp. common stockholders	$	(4,520,653)	$	(1,647,629)	$	(24,765,069)	$	(12,347,125)

The accompanying notes are an integral part of these condensed consolidated financial statements.

NUVVE HOLDING CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)



	Preferred Class A Units	Class B Units			Common Stock			Treasury Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit			Non-controlling Interests		Total
		Shares	Amount		Shares	Amount		Shares	Amount			Shares					Amount
Balances December 31, 2024		—	$	—	—	—		903,269	$	6,408	1,680		$	—	$	164,285,336		$	46,494	$	(165,599,076)	$	(28,809)	$	(1,289,647)

Stock-based compensation		—	—		—	—		—	—		—		—		554,659			—		—		—		554,659
Proceeds from direct offering, net of offering costs		—	—		—	—		213,428	21		—		—		564,847			—		—		—		564,868


Exercise of warrants/warrants issuance		—	—		—	—		431,652	43		—		—		854,053			—		—		—		854,096
Conversion of convertible notes, net of offering costs		—	—		—	—		1,568,019	157		—		—		2,952,426			—		—		—		2,952,583
Currency translation adjustment		—	—		—	—		—	—		—		—		—			236		—		—		236


Net loss		—	—		—			—	—		—		—		—			—		(6,873,003)		(5,598)		(6,878,601)
Balances March 31, 2025		—	—		—	—		3,116,368	6,629		1,680		—		169,211,321			46,730		(172,472,079)		(34,407)		(3,241,806)

Stock-based compensation		—	—		—	—		—	—		—		—		14,022			—		—		—		14,022




Exercise of warrants		—	—		—	—		1,651,643	165		—		—		1,221,084			—		—		—		1,221,249
Warrants issuance		—	—		—	—		—	—		—		—		8,194,000			—		—		—		8,194,000
Conversion of convertible notes, net of offering costs		—	—		—	—		6,153,330	609		—		—		3,670,020			—		—		—		3,670,630
Preferred Class A units issuance		4,900,000	774,976		—	—		—	—		—		—		—			—		—		—		774,976
Class B units issuance		—	—		100,000	100,000		—	—		—		—		—			—		—		—		100,000
Currency translation adjustment		—	—		—	—		—	—		—		—		—			7,151		—		—		7,151


Net loss		—	—		—	—		—	—		—		—		—			—		(13,378,800)		(189,662)		(13,568,462)
Balances June 30, 2025		4,900,000	774,976		100,000	100,000		10,921,341	7,404		1,680		—		182,310,448			53,881		(185,850,879)		(224,069)		(2,828,239)


Stock-based compensation		—	—		—	—		—	—		—		—		245,624			—		—		—		245,624

Proceeds from common stock offering, net of offering costs		—	—		—	—		3,798,874	380		—		—		3,058,782			—		—		—		3,059,162
Conversion of convertible notes, net of offering costs		—	—		—	—		6,204,740	625		—		—		1,075,838			—		—		—		1,076,463
Issuance of Pre-funded Warrants		—	—		—	—		1,507,795	151		—		—		1,885,693			—		—		—		1,885,844
Exercise of Warrants		—	—		—	—		50,000	5		—		—		8,550			—		—		—		8,555
Preferred Class A units issuance - adjustment		—	(608,278)		—	—		—	—		—		—		—			—		—		—		(608,278)
Class B units issuance		—	—		50,000	50,000		—	—		—		—		—			—		—		—		50,000
Currency translation adjustment		—	—		—	—		—	—		—		—		—			(13,393)		—		—		(13,393)



Net loss								—	—		—		—		—			—		(4,507,260)		(286,955)		(4,794,215)
Balances September 30, 2025		4,900,000	$	166,698	150,000	$	150,000	22,482,750	$	8,565	1,680		$	—	$	188,584,935		$	40,488	$	(190,358,139)	$	(511,024)	$	(1,918,477)

The accompanying notes are an integral part of these condensed consolidated financial statements.

NUVVE HOLDING CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

(Unaudited)


	Common Stock	Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit			Non-controlling Interests		Total
			Shares					Amount
Balances December 31, 2023		124,659		$	5,927	$	155,615,962		$	93,676	$	(148,240,859)	$	(4,894,101)	$	2,580,605
Exercise of stock options and vesting of restricted stock		17,414		18		(18)			—		—		—		—
Stock-based compensation		—		—		846,514			—		—		—		846,514

Proceeds from common stock offering, net of offering costs		303,500		304		5,029,118			—		—		—		5,029,422

Issuance of Pre-funded Warrants		161,492		108		—			—		—		—		108

Currency translation adjustment		—		—		—			(13,651)		—		—		(13,651)
Preferred dividends - non-controlling interest		—		—		—			—		—		(75,004)		(75,004)
Accretion on redeemable non-controlling interests preferred shares		—		—		—			—		—		(161,466)		(161,466)
Net loss		—		—		—			—		(6,714,438)		(14,299)		(6,728,737)
Balances March 31, 2024		607,064		6,357		161,491,576			80,025		(154,955,297)		(5,144,870)		1,477,791
Exercise of stock options and vesting of restricted stock		661		1		(1)			—		—		—		—
Stock-based compensation		—		—		481,800			—		—		—		481,800



Issuance of Pre-funded warrants		14,998		15		(15)			—		—		—		—
Exercise of Warrants		30,000		30		172,967			—		—		—		172,997
Currency translation adjustment		—		—		—			(8,093)		—		—		(8,093)
Preferred dividends - non-controlling interest		—		—		—			—		—		(76,504)		(76,504)
Accretion on redeemable non-controlling interests preferred shares		—		—		—			—		—		(161,466)		(161,466)
Net loss		—		—		—			—		(3,938,747)		(10,268)		(3,949,015)
Balances June 30, 2024		652,723		6,403		162,146,327			71,932		(158,894,044)		(5,393,108)		(2,062,490)
Common stock reverse split - rounding		192,222		—		—			—		—		—		—
Exercise of stock options and vesting of restricted stock		4		—		—			—		—		—		—
Stock-based compensation		—		—		601,075			—		—		—		601,075




Exercise of Warrants		30,000		3		239,700			—		—		—		239,703
Currency translation adjustment		—		—		—			2,214		—		—		2,214


Cancellation of non-controlling interests		—		—		481,220			—		—		5,393,108		5,874,328
Net loss		—		—		—			—		(1,649,843)		—		(1,649,843)
Balances September 30, 2024		874,949		$	6,406	$	163,468,322		$	74,146	$	(160,543,887)	$	—	$	3,004,987

The accompanying notes are an integral part of these condensed consolidated financial statements.

NUVVE HOLDING CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	Nine Months Ended September 30,
	2025		2024
Operating activities
Net loss	$	(25,241,278)	$	(12,327,595)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	245,796		254,275
Stock-based compensation	814,305		1,991,884


Amortization of discount on debt and promissory notes	166,611		24,167
Change in fair value of warrants/investment rights liability	(673,899)		(2,642,424)
Change in fair value of convertible notes	60,663		—
Change in fair value of derivative liability	—		3,626
Fair value of warrants issued for cryptocurrency strategy consulting services	8,194,000		—
Loss on warrants issuance	—		305,065


Provision for credit losses	990,105		—
Noncash lease expense	592,386		223,892
Change in operating assets and liabilities
Accounts receivable	48,838		56,361
Inventory	336,785		230,712
Prepaid expenses and other assets	(1,542,242)		728,999
Accounts payable	1,062,150		490,130

Accrued expenses and other liabilities	2,146,135		(1,524,707)
Deferred revenue	451,661		(57,207)
Net cash used in operating activities	(12,347,984)		(12,242,822)
Investing activities

Acquisition	(340,200)		—
Purchase of property and equipment	(57,099)		(54,630)



Net cash used in investing activities	(397,299)		(54,630)
Financing activities












Proceeds from exercise of warrants	2,083,900		173,027
Proceeds from debt and promissory notes obligations	8,972,199		2,565,500
Repayment of debt and promissory notes obligations	(3,401,943)		(161,929)

Proceeds from common stock offering, including pre-funded warrants, net of issuance costs	5,509,874		8,516,741

Payment of finance lease obligations	(6,835)		(7,816)
Proceeds from issuance of Class B units	150,000		—





Net cash provided in financing activities	13,307,195		11,085,523
Effect of exchange rate on cash	6,006		2,514
Net increase (decrease) in cash and restricted cash	567,918		(1,209,415)
Cash and restricted cash at beginning of year	691,497		2,014,660
Cash and restricted cash at end of period	$	1,259,415	$	805,245


Supplemental Disclosure of cash information:
Cash paid for interest	$	1,096,650	$	193,322


Supplemental Disclosure of Noncash Investing and Financing Activities:
Conversion of Notes and accrued interest to common shares	$	10,132,855	$	—
Payment of Promissory with Contingent Receivable	$	283,578	$	—
Issuance of preferred class A units for acquisition	$	166,698	$	—


The accompanying notes are an integral part of these condensed consolidated financial statements.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Organization and Description of Business

Description of Business

Nuvve Holding Corp., a Delaware corporation headquartered in San Diego, California (the “Company” or “Nuvve”), was founded on November 10, 2020 under the laws of the state of Delaware. On March 19, 2021, the Company (at the time known as NB Merger Corp.) acquired the outstanding shares of Nuvve Corporation (“Nuvve Corp.”), and the Company changed its name to Nuvve Holding Corp.

Reverse Stock Split

At the Company’s Special Meeting of Stockholders held on January 5, 2024, the Company’s stockholders approved a proposal to authorize a reverse stock split of the Company’s common stock, at a ratio within the range of 1-for-2 to 1-for-40. The Board of Directors (the "Board") approved a 1-for-40 reverse split ratio, and on January 19, 2024, the Company filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company with the Secretary of State of the State of Delaware to effect the reverse split effective January 19, 2024 (the “January 2024 Reverse Stock Split”). The January 2024 Reverse Stock Split is already reflected in the year ended December 31, 2023 consolidated financial statement balances.

Additionally, at the Company’s Annual Meeting of Stockholders held on September 9, 2024, the Company’s stockholders approved a proposal to authorize a reverse stock split of the Company’s common stock, at a ratio within the range of 1-for-2 to 1-for-10. The Board approved a 1-for-10 reverse split ratio, and on September 16, 2024, the Company filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company with the Secretary of State of the State of Delaware to effect the reverse split effective September 17, 2024 (the “September 2024 Reverse Stock Split” and together with the January 2024 Reverse Stock Split, the “Reverse Stock Splits”).

The Reverse Stock Splits were also applicable to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable were adjusted proportionately as a result of the Reverse Stock Splits. The exercise prices of any outstanding warrants or stock options were also proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans. The Reverse Stock Splits did not affect the number of authorized shares of the Company's common stock or the par value of the common stock. All issued and outstanding common stock, options to purchase common stock, warrants to purchase common stock and per share amounts contained in the condensed consolidated financial statement have been retroactively adjusted to reflect each of the January 2024 Reverse Stock Split and the September 2024 Reverse Stock Split for all periods presented.

Structure of the Company

Nuvve has four wholly owned subsidiaries, Nuvve Corp., Nuvve CPO Inc., Hype Strategy LLC, and Nuvve Japan Corporation. Nuvve Corp. has four wholly owned subsidiaries or branches: (1) Nuvve Denmark ApS, (“Nuvve Denmark”), a company registered in Denmark, (2) Nuvve SaS, a company registered in France as a branch of Nuvve Corp, (3) Nuvve KK (Nuvve Japan), a company registered in Japan, and (4) Nuvve LTD, a company registered in United Kingdom. Nuvve CPO Inc., or Nuvve Charge Point Operator, was established in August 2024 to support the deployment and ongoing support of the Company's customers charging station networks.

Deep Impact

On August 16, 2024, the Company, Nuvve CPO, and WISE EV-LLC (“WISE”), entered into the definitive agreements to form Deep Impact 1 LLC, a Delaware limited liability company (“Deep Impact”) in which the Company holds a 51% equity interest by way of Nuvve CPO, and in which WISE holds a 49% equity interest. Deep Impact is an entity formed for the principal purpose of operation, installation, maintenance of electric vehicle chargers and other related activities and services created as a business venture between the Company, Nuvve CPO and Wise.

In connection with the formation of Deep Impact, Nuvve CPO, WISE and Deep Impact entered into a Contribution and Unit Purchase Agreement (the “Contribution Agreement”), pursuant to which Nuvve CPO and WISE agreed to contribute $51 and $49, respectively to the Deep Impact, and to provide certain services pursuant to separate services agreements to Deep Impact. For such contributions and the services, Nuvve CPO received 51 membership units in Deep Impact, equal to a 51% equity interest, and WISE received 49 membership units in Deep Impact, equal to a 49% equity interest. Please see Note 2 for the principles of consolidation. Deep Impact had limited business operations during the three and nine months ended September 30, 2025 and year ended December 31, 2024.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Fermata Energy II LLC

On April 25, 2025, the Company, Fermata Energy LLC (“Seller”), and the former noteholders of the Seller (the “Preferred Members”), entered into a series of definitive agreements to effect the acquisition of substantially all of the Seller’s assets by Fermata Energy II, LLC, a Delaware limited liability company (“Fermata”). As a result of the transaction, the Company holds a 51% equity interest in Fermata as the sole common units member, and the Preferred Members collectively hold the remaining 49% equity interest in the form of class A preferred units. The class A preferred unit holders are entitled to a compounded 10.0% annual preferred return. Fermata is an entity formed for the principal purpose of developing and commercializing energy management and bidirectional charging technology solutions. Please see Note 20 for details of the acquisition.

Nuvve New Mexico LLC

In April 2025, the Company formed Nuvve New Mexico LLC, a new subsidiary created to support the Company’s recently awarded State of New Mexico contract. The new entity serves as a regional representative company, ensuring the successful execution of the contract and the expansion of the Company's innovative energy solutions across the state. The Company holds majority membership interest in Nuvve New Mexico LLC as the Class A units holder. Other members admitted into the Nuvve New Mexico LLC through subscription as investors holds the Class B units, and are entitled to a cumulative 18.0% annual preferred return on unreturned capital contribution. As of September 30, 2025, two members have been admitted as a Class B unit members with an aggregate subscription of 150,000 Class B units at $1.00 per unit.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 2 – Summary of Significant Accounting Policies

For a detailed discussion about the Company’s significant accounting policies, see Note 2, “Summary of Significant Accounting Policies,” in the Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 (the “2024 Form 10-K”).

During the nine months ended September 30, 2025, there were no significant updates made to the Company’s significant accounting policies.

Basis of Presentation

The accompanying (i) unaudited condensed consolidated balance sheet as of December 31, 2024, which has been derived from audited financial statements, and (ii) unaudited interim condensed consolidated financial statements have been prepared in accordance pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. Therefore, it is recommended that these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes in the 2024 Form 10-K, filed with the SEC on March 31, 2025.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss, cash flows, and total equity for the interim periods, but are not necessarily indicative of the results to be anticipated for the full year 2025 or any future period.

In accordance with the related Going Concern accounting standards, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the consolidated financial statements are issued. Since inception, the Company has incurred recurring losses and negative cash flows from operations and has an accumulated deficit of $190.4 million and $165.6 million as of September 30, 2025 and December 31, 2024, respectively. The Company incurred operating losses of approximately $25.5 million as of the nine months ended September 30, 2025, and $20.5 million and $32.1 million for the years ended December 31, 2024, and 2023, respectively. The Company's cash used in operations was $12.3 million for the nine months ended September 30, 2025, and $15.7 million and $21.3 million for the years ended December 31, 2024, and 2023, respectively. As of September 30, 2025, the Company had a cash balance, negative working capital, and total deficit of $0.9 million, $3.4 million and $1.9 million, respectively. The Company continues to expect to generate operating losses and negative cash flows and will need additional funding to support its planned operating activities through profitability and to repay its $2.2 million of debt due within a year after these financial statements are issued. The transition to profitability is dependent upon the successful expanded commercialization of the Company's GIVe platform and the achievement of a level of revenues adequate to support its cost structure.

Management plans to fund current operations and satisfy its other obligations through increased revenues and raising additional capital. Management's expectations with respect to the Company’s ability to fund current operations and its other obligations is based on estimates that are subject to risks and uncertainties. There is an inherent risk that the Company may not achieve such financial projections and if so, cash outflows could be higher than currently anticipated. However, as such plans are not solely within management’s control, management cannot conclude as of the date of this filing that the plans are probable of being successfully implemented and as such has concluded that substantial doubt exists about the Company’s ability to continue as a going concern for twelve months from the date of issuance of our financial statements.

The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Principles of Consolidation

The condensed consolidated financial statements include the accounts and operations of the Company, its wholly owned subsidiaries and its consolidated variable interest entity. All intercompany accounts and transactions have been eliminated upon consolidation.

Variable Interest Entities

Pursuant to the consolidation guidance, the Company first evaluates whether it holds a variable interest in an entity in which it has a financial relationship and, if so, whether or not that entity is a variable interest entity ("VIE"). A VIE is an entity with insufficient equity at risk for the entity to finance its activities without additional subordinated financial support or in which equity investors lack the characteristics of a controlling financial interest. If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company concludes that it is the primary beneficiary and consolidates the VIE if the Company has both (i) the power to direct the activities of the VIE that most significantly influence the VIE's economic performance, and (ii) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE.

The Company formed Deep Impact with Nuvve CPO and WISE, in which the Company owned 51% of Deep Impact's common units (See Note 1). The Company has determined that Deep Impact is a VIE in which the Company is the primary beneficiary. Accordingly, the Company consolidates Deep Impact and records a non-controlling interest for the share of the entity owned by WISE.

Assets and Liabilities of Consolidated VIEs

The Company's condensed consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are reflected in "Net income (loss) attributable to non-controlling interests" in the condensed consolidated statements of operations and "Non-controlling interests" in the condensed consolidated balance sheets. See Note 18 for details of non-controlling interests.

The creditors of the consolidated VIE do not have recourse to the Company other than to the assets of the consolidated VIE. The following table summarizes the carrying amounts of the Company's VIE assets and liabilities included in the Company’s condensed consolidated balance sheets at September 30, 2025 and December 31, 2024:


	September 30, 2025		December 31, 2024
Assets

Cash	$	2,937	$	10,404




Inventories	183,219		$	—
Intercompany loan receivable	—		$	930,019
Prepaid expenses and other current assets	117,279		52,190
Total Current Assets	303,435		992,613
Property and equipment, net	79,000		—
Intangible assets, net	149,000		—
Goodwill	96,000		—
Intercompany receivable	2,482,005		—
Security deposit, long-term	18,489		—
Total Assets	$	3,127,929	$	992,613

Liabilities

Accounts payable	$	37,397	$	166,681
Accrued expenses and dividend payable	33,594		—
Promissory notes	1,754,391		884,676
Intercompany payable	1,519,492		—








Total Liabilities	$	3,344,874	$	1,051,357

Non-controlling interests

The Company presents non-controlling interests as a component of equity on its condensed consolidated balance sheets and reports the portion of its earnings or loss for non-controlling interest as net earnings or loss attributable to non-controlling interests in the condensed consolidated statements of operations.

Emerging Growth Company

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) permits emerging growth companies (“EGC”) to delay complying with new or revised financial accounting standards that do not yet apply to private companies (that is, those that have not had a registration statement under the Securities Act of 1933, as amended (the “Securities Act”), declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the Exchange Act")). The Company qualifies as an EGC. The JOBS Act provides that an EGC can elect to opt-out of the extended transition period and comply with the requirements that apply to non-EGCs, but any such election to opt-out is irrevocable. The Company has elected not to opt-out of such an extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an EGC, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This different adoption timing may make a comparison of the Company’s financial statements with another public company, which is neither an EGC nor an EGC that has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made by management include the impairment of intangible assets, the net realizable value of inventory, the fair value of share-based payments, lease incremental borrowing rate, derivative liability associated with redeemable preferred shares, revenue recognition, the fair value of warrants, annual bonus accrual, and the recognition and disclosure of contingent liabilities.

Management evaluates its estimates on an ongoing basis. Actual results could materially vary from those estimates.

Cash and Restricted Cash

The Company maintains cash balances that can, at times, exceed amounts insured by the Federal Deposit Insurance Corporation, which is up to $250,000. The Company has not experienced any losses in these accounts and believes it is not exposed to any significant credit risk in this area. In connection with a new office lease agreement, the Company was required to provide an irrevocable, unconditional letter of credit to the landlord upon execution of the lease. The amount securing the letter of credit was recorded as restricted cash as of September 30, 2025 and December 31, 2024 was $320,000.

Concentrations of Credit Risk

At September 30, 2025 and December 31, 2024, the financial instruments which potentially expose the Company to concentration of credit risk consist of cash in financial institutions (in excess of federally insured limits) and trade receivables.

The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows:

For the three and nine months ended September 30, 2025, two customers accounted for 35.2% and 27.8% of revenue, respectively. For the three and nine months ended September 30, 2024, three customers accounted for 60.5% and 35.7% of revenue, respectively.

During the three and nine months ended September 30, 2025, the Company's top five customers accounted for approximately 72.4% and 49.8% of the Company’s total revenue, respectively. During the three and nine months ended September 30, 2024, the Company's top five customers accounted for approximately 72.3% and 49.2% of the Company’s total revenue.

At September 30, 2025, three customers accounted for 53.4% of accounts receivable. At December 31, 2024, three customers accounted for 71.6% of accounts receivable.

Approximately 68.4% and 81.3% of the Company’s trade accounts receivable balance was with five customers at September 30, 2025 and December 31, 2024, respectively. The Company estimates its maximum credit risk for accounts receivable at the amount recorded on the balance sheet. The trade accounts receivables are generally short-term and all probable bad debt losses have been appropriately considered in establishing the allowance for doubtful accounts.

Recently adopted accounting pronouncements

None Applicable

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Recently issued accounting pronouncements not yet adopted

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosures. ASU 2023-09 requires disclosure of disaggregated income taxes paid in both U.S. and foreign jurisdictions, prescribes standard categories for the components of the effective tax rate reconciliation and modifies other income tax-related disclosures. ASU 2023-09 is effective for the Company’s annual year ending December 31, 2025. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses. ASU 2024-03 requires a public business entity ("PBE") to disclose, on an annual and interim basis, additional information about certain costs and expenses in the notes to financial statements. Specifically, in a tabular disclosure, the amounts of (a) purchases of inventory; (b) employee compensation; (c) depreciation; (d) intangible asset amortization; and (e) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities (or other amounts of depletion expense) included in each relevant expense caption. Within the same tabular disclosure, a PBE is required to include certain expense, gain, or loss amounts that are already required to be disclosed under U.S. GAAP. Additionally, a PBE is required to disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. The guidance also requires a PBE to disclose the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. Effective for annual periods beginning after December 15, 2026, and for interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption on its financial statement disclosures.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 3 – Revenue Recognition

The disclosures below discuss the Company’s material revenue contracts.

The following table provides information regarding disaggregated revenue:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Revenue recognized over time:
Services - engineering and others (1)	$	372,749	$	1,111,863	$	747,843	$	1,478,363
Grid services	8,127		153,636		91,421		308,574
Grants	270,190		108,885		349,800		323,722
Revenue recognized at point in time:
Products	947,561		543,834		1,655,017		1,389,495
Total revenue	$	1,598,627	$	1,918,218	$	2,844,081	$	3,500,154

__________________

(1) The nine months ended September 30, 2025 amount includes $177,332 of management fees earned related to Fresno EV infrastructure project management which is fully reflected in the provision for credit losses.

The aggregate amount of revenue for the Company’s existing contracts and grants with customers as of September 30, 2025 expected to be recognized in the future, and classified as deferred revenue on the condensed consolidated balance sheet, for year ended December 31, is as follows (this disclosure does not include revenue related to contracts whose original expected duration is one year or less):


2025 (remaining three months)	$	622,775
2026	569,441
2027	208,073
2028	173,071
Thereafter	154,025
Total (1)	$	1,727,385

__________________

(1) The revenue recognition is subject to the completion of construction and commissioning of the EV infrastructure.

The following table summarizes the Company’s revenues by geography:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Revenues:
United States	$	1,578,043	$	1,814,904	$	2,676,995	$	3,316,968

Denmark	20,584		103,314		167,086		183,186
	$	1,598,627	$	1,918,218	$	2,844,081	$	3,500,154

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 4 – Fair Value Measurements

The following are the liabilities measured at fair value on the condensed consolidated balance sheet at September 30, 2025 and December 31, 2024 using quoted price in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):


	Level 1: Quoted Prices in Active Markets for Identical Assets		Level 2: Significant Other Observable Inputs		Level 3: Significant Unobservable Inputs		Total at September 30, 2025		Total Gains (Losses) For The Three Months Ended September 30, 2025		Total Gains (Losses) For The Nine Months Ended September 30, 2025
Recurring fair value measurements




2024 February Institutional/Accredited Investor warrants	$	—	$	—	$	620	$	620	$	91,092	$	290,946
2024 October Institutional/Accredited Investor Warrants	$	—	$	—	$	13,989	$	13,989	$	(7,015)	$	278,245
Senior Convertible Notes - October 2024	$	—	$	—	$	33,623	$	33,623	$	(4,623)	$	(123,384)
Additional Investment Rights - October 2024	$	—	$	—	$	111,107	$	111,107	$	(100,774)	$	(105,157)
2024 December Institutional/Accredited Investor Warrants	$	—	$	—	$	81	$	81	$	48,627	$	109,256
2025 March Institutional/Accredited Investor Warrants	$	—	$	—	$	53,587	$	53,587	$	(17,330)	$	52,957


2025 April Institutional/Accredited Investor Warrants	$	—	$	—	$	40,638	$	40,638	$	(8,955)	$	(8,955)

2025 May Institutional/Accredited Investor Warrants	$	—	$	—	$	188,467	$	188,467	$	(48,550)	$	(48,550)
Senior Convertible Notes - May 2025	$	—	$	—	$	895,497	$	895,497	$	167,878	$	167,878
2025 September Institutional/Accredited Investor Warrants	$	—	$	—	$	965	$	965	$	—	$	—
Senior Convertible Notes - September 2025	$	—	$	—	$	100,926	$	100,926	$	—	$	—
Total recurring fair value measurements	$	—	$	—	$	1,439,500	$	1,439,500	$	120,350	$	613,236


	Level 1: Quoted Prices in Active Markets for Identical Assets		Level 2: Significant Other Observable Inputs		Level 3: Significant Unobservable Inputs		Total at December 31, 2024		Total Gains (Losses) For The Three Months Ended September 30, 2024		Total Gains (Losses) For The Nine Months Ended September 30, 2024
Recurring fair value measurements

2022 July Institutional/Accredited Investor Warrants	$	—	$	—	$	—	$	—	$	—	4,621
Private warrants - July 2024	$	—	$	—	$	—	$	—	$	80,673	$	80,673
2024 February Institutional/Accredited Investor warrants	$	—	$	—	$	291,566	$	291,566	$	728,663	3,036,476
2024 October Institutional/Accredited Investor Warrants	$	—	$	—	$	292,234	$	292,234	$	—	$	—
Senior Convertible Notes - October 2024	$	—	$	—	$	2,475,162	$	2,475,162	$	—	—
Additional Investment Rights - October 2024	$	—	$	—	$	5,950	$	5,950	$	—	$	—
2024 December Institutional/Accredited Investor Warrants	$	—	$	—	$	109,337	$	109,337	$	—	—
Derivative liability - non-controlling redeemable preferred shares	$	—	$	—	$	—	$	—	$	—	$	(3,626)
Total recurring fair value measurements	$	—	$	—	$	3,174,249	$	3,174,249	$	809,336	$	3,118,144

The following is a reconciliation of the opening and closing balances for the liabilities related to the warrants (Note 11) and derivative liability - non-controlling redeemable preferred shares measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2025:

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)


	2024 February Institutional/Accredited Investor warrants		2024 October Institutional/Accredited Investor Warrants		Senior Convertible Notes - October 2024		Additional Investment Rights - October 2024		2024 December Institutional/Accredited Investor Warrants		2025 March Institutional/Accredited Investor Warrants		Senior Convertible Notes - March 2025		2025 April Institutional/Accredited Investor Warrants		2025 May Institutional/Accredited Investor Warrants		Senior Convertible Notes - May 2025		2025 September Institutional/Accredited Investor Warrants		Senior Convertible Notes - September 2025

Balance at December 31, 2024	$	291,566	$	292,234	$	2,475,162	$	5,950	$	109,337	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Initial fair value	—		—		—		—		—		106,544		1,393,456		—		—		—		—		—
Conversion of Convertible Notes	—		—		(3,058,031)		—		—		—		—		—		—		—		—		—
Total (gains) losses for period included in earnings	(217,896)		(265,178)		1,091,006		676,717		(69,025)		—		—		—		—		—		—		—
Balance at March 31, 2025	73,670		27,056		508,137		682,667		40,312		106,544		1,393,456		—		—		—		—		—
Initial fair value	—														31,683		139,917		2,135,181		—		—
Conversion of Convertible Notes	—		—		617,017		—		—		—		(1,393,456)		—		—		—		—		—
Total (gains) losses for period included in earnings	18,042		(20,082)		(972,245)		(672,334)		8,396		(70,287)		—		—		—		—		—		—
Balance at June 30, 2025	91,712		6,974		152,909		10,333		48,708		36,257		—		31,683		139,917		2,135,181		—		—
Initial fair value	—		—		—		—		—		—		—		—		—		—		965		100,926
Exercise warrants	—		—		—		—		—		—		—		—		—		—		—		—
Conversion of Convertible Notes	—		—		(123,909)		—		—		—		—		—		—		(1,071,806)		—		—
Total (gains) losses for period included in earnings	(91,092)		7,015		4,623		100,774		(48,627)		17,330		—		8,955		48,550		(167,878)		—		—
Balance at September 30, 2025	$	620	$	13,989	$	33,623	$	111,107	$	81	$	53,587	$	—	$	40,638	$	188,467	$	895,497	$	965	$	100,926

The fair value of the level 3 2022 July Institutional/Accredited Investor warrants was estimated at December 31, 2024 using the Black-Scholes model which used the following inputs: term of 3.00 years, risk free rate of 4.47%, no dividends, volatility of 57.0%, common stock price of $3.12, and strike price of $1,500.00.

The fair value of the level 3 2024 February Institutional/Accredited Investor warrants was estimated at September 30, 2025 using the Black-Scholes model which used the following inputs: term of 3.35 years, risk free rate of 3.63%, no dividends, volatility of 81.0%, common stock price of $0.24, and strike price of $20.00.

The fair value of the level 3 2024 February Institutional/Accredited Investor warrants was estimated at December 31, 2024 using the Black-Scholes model which used the following inputs: term of 4.09 years, risk free rate of 4.33%, no dividends, volatility of 85.0%, common stock price of $3.12, and strike price of $20.00.

The fair value of the level 3 2024 October Institutional/Accredited Investor Warrants was estimated at September 30, 2025 using the Monte Carlo Simulation model which used the following inputs: term of 4.08 years, risk free rate of 3.80%, no dividends, volatility of 45.4%, common stock price of $0.24, and strike price of $3.78.

The fair value of the level 3 2024 October Institutional/Accredited Investor Warrants was estimated at December 31, 2024 using the Monte Carlo Simulation model which used the following inputs: term of 4.80 years, risk free rate of 4.20%, no dividends, volatility of 49.6%, common stock price of $3.12, and strike price of $3.78.

The fair value of the level 3 Senior Convertible Notes - October 2024 was estimated at September 30, 2025 using the Monte Carlo Simulation model which used the following inputs: term of 0.58 years, risk free rate of 3.80%, no dividends, volatility of 45.4%, common stock price of $0.24, and strike price of $3.78.

The fair value of the level 3 Senior Convertible Notes - October 2024 was estimated at December 31, 2024 using the Monte Carlo Simulation model which used the following inputs: term of 1.33 years, risk free rate of 4.20%, no dividends, volatility of 49.6%, common stock price of $3.12, and strike price of $3.40.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

The fair value of the level 3 Additional Investment Rights - October 2024 was estimated at September 30, 2025 using the Monte Carlo Simulation model which used the following inputs: term of 0.58 years, risk free rate of 3.80%, no dividends, volatility of 45.4%, common stock price of $0.24, and strike price of $3.78.

The fair value of the level 3 Additional Investment Rights - October 2024 was estimated at December 31, 2024 using the Monte Carlo Simulation model which used the following inputs: term of 1.33 years, risk free rate of 4.20%, no dividends, volatility of 49.6%, common stock price of $3.12, and strike price of $3.40.

The fair value of the level 3 2024 December Institutional/Accredited Investor Warrants was estimated at September 30, 2025 using the Black-Scholes model which used the following inputs: term of 4.30 years, risk free rate of 3.80%, no dividends, volatility of 45.4%, common stock price of $0.24, and strike price of $3.26.

The fair value of the level 3 2024 December Institutional/Accredited Investor Warrants was estimated at December 31, 2024 using the Black-Scholes model which used the following inputs: term of 5.00 years, risk free rate of 4.33%, no dividends, volatility of 85.0%, common stock price of $3.12, and strike price of $3.26.

The fair value of the level 3 2025 March Institutional/Accredited Investor Warrants was estimated at September 30, 2025 using the Monte Carlo Simulation model which used the following inputs: term of 4.43 years, risk free rate of 3.70%, no dividends, volatility of 46.6%, common stock price of $0.24, and strike price of $0.74.

The fair value of the level 3 2025 April Institutional/Accredited Investor Warrants was estimated at September 30, 2025 using the Monte Carlo Simulation model which used the following inputs: term of 4.58 years, risk free rate of 3.70%, no dividends, volatility of 46.6%, common stock price of $0.24, and strike price of $0.74.

The fair value of the level 3 2025 May Institutional/Accredited Investor Warrants was estimated at September 30, 2025 using the Monte Carlo Simulation model which used the following inputs: term of 4.67 years, risk free rate of 3.70%, no dividends, volatility of 46.6%, common stock price of $0.24, and strike price of $0.74.

The fair value of the level 3 Senior Convertible Notes - May 2025 was estimated at September 30, 2025 using the Monte Carlo Simulation model which used the following inputs: term of 1.18 years risk free rate of 3.70%, no dividends, volatility of 46.6%, common stock price of $0.24, and strike price of $0.74.

The fair value of the level 3 2025 September Institutional/Accredited Investor Warrants was estimated at September 30, 2025 using the Monte Carlo Simulation model which used the following inputs: term of 4.94 years, risk free rate of 3.60%, no dividends, volatility of 46.2%, common stock price of $0.24, and strike price of $0.17.

The fair value of the level 3 Senior Convertible Notes - September 2025 was estimated at September 30, 2025 using the Monte Carlo Simulation model which used the following inputs: term of 1.46 years risk free rate of 3.60%, no dividends, volatility of 46.2%, common stock price of $0.24, and strike price of $0.17.

There were no transfers between Level 1 and Level 2 of the fair value hierarchy in 2025 and 2024.

Cash, accounts receivable, accounts payable, and accrued expenses are generally carried on the cost basis, which management believes approximates fair value due to the short-term maturity of these instruments.

Other Debt Obligations

The following outstanding debt obligations are reflected in the Company's condensed consolidated balance sheet at carrying value since the Company did not elect to remeasure the debt obligations to fair value at the end of each reporting period. The carrying values of these debt obligations approximate fair value due to the short-term maturity of these debt obligations.


	September 30, 2025				December 31, 2024
	Fair Value		Carrying Value		Fair Value		Carrying Value
Term loan	$	627,727	$	627,727	$	1,445,345	$	1,445,345
Promissory Notes - August 16, 2024	$	853,841	$	853,841	$	884,676	$	884,676
Promissory Notes - August 27, 2024	$	—	$	—	$	516,818	$	516,818

Senior Convertible Notes - December 2024(1)	$	30,443	30,443		$	250,000	$	250,000
Promissory Notes - Fermata Energy II LLC	$	570,616	$	570,616	$	—	$	—

__________________

(1) Amount is net of conversions.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 5 – Investments

The Company accounts for its 4.65% equity ownership in Dreev as an investment in equity securities without a readily determinable fair value subject to impairment. The Company has a consulting services agreement with Dreev related to software development and operations. The consulting services were zero for the three and nine months ended September 30, 2025 and September 30, 2024. The consulting services are being provided to Dreev at the Company’s cost and is recognized as other income, net in the condensed consolidated statements of operations.

On October 8, 2025, the Company entered into a Share Purchase Agreement with EDF and Dreev, pursuant to which the Company agreed to sell to EDF all of the equity interests of Dreev held by the Company, representing approximately 4.65% of the total interests of Dreev. In exchange, EDF agreed to pay the Company a lump sum payment of 800,000 Euros.

Note 6 – Account Receivables, Net

The following tables summarizes the Company's accounts receivable:


		September 30, 2025		December 31, 2024

Trade receivables		$	2,415,882	$	2,463,821

Less: allowance for credit losses		(1,306,627)		(315,623)

	Accounts receivable, net	$	1,109,255	$	2,148,198

Allowance for credit losses:

	Balance December 31, 2024	$	(315,623)
	Provision (1)	(991,004)
	Write-off	—
	Recoveries	—
	Balance at September 30, 2025	$	(1,306,627)

__________________

(1) $990,105 of the total amount is related to prior recognized management fees earned in the Fresno EV infrastructure project management.

Note 7 – Inventories

The following table summarizes the Company’s inventories balance by category:


	September 30, 2025		December 31, 2024
DC Chargers	$	3,700,167	$	3,966,115
AC Chargers	334,100		474,154

Component parts and Carbon Credit	220,850		151,633
Total	$	4,255,117	$	4,591,902

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 8 – Property, Plant and Equipment

The following table summarizes the Company’s property, plant and equipment balance:


	Useful Lives			September 30, 2025		December 31, 2024


Computers & Servers	1 year	to	3 years	$	176,716	$	171,977
Vehicles	5 years	to	7 years	65,754		65,414

Office furniture and equipment	3 years	to	5 years	445,323		366,323
Test units and loaned chargers (1)	5 years	to	7 years	744,222		621,707
Total				1,432,015		1,225,421
Less: Accumulated Depreciation				(765,425)		(611,463)
Property, plant and equipment, net				$	666,590	$	613,958


	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Depreciation expense	$	46,374	$	48,963	$	137,079	$	151,847

__________________

(1) Represents DC Chargers temporarily loaned out to customers while their DC Chargers are being repaired.

Note 9 – Intangible Assets and Goodwill

Intangible Assets

At both September 30, 2025 and December 31, 2024, the Company had recorded a gross intangible asset balance of $2,240,594, which is related to patent and intangible property rights acquired. Amortization expense of intangible assets was $34,860 for each of the three months ended September 30, 2025 and 2024. Amortization expense of intangible assets was $108,718 and $104,578 for the nine months ended September 30, 2025 and 2024, respectively. Accumulated amortization totaled $1,137,508 and $1,028,790 at September 30, 2025 and December 31, 2024, respectively.

The net amount of intangible assets of $1,103,048 at September 30, 2025, will be amortized over the weighted average remaining life of 9.15 years.

Total estimated future amortization expense is as follows:


2025 (remaining three months)	$	37,343
2026	147,706
2027	142,706
2028	142,706
2029	142,706
Thereafter	489,881
	$	1,103,048

Goodwill

The following table summarizes the Company’s goodwill balance:


	September 30, 2025		December 31, 2024
Beginning Balance	$	—	$	—
Additions - Fermata acquisition	703,957		—
Fermata acquisition - final purchase price adjustments	(607,957)		—
Total	$	96,000	$	—

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 10 – Debt

The following is a summary of debt as of September 30, 2025 and December 31, 2024:


	September 30, 2025		December 31, 2024
Term loan	$	627,727	$	1,445,345
Promissory Notes - August 16, 2024 (3)	853,841		884,676
Promissory Notes - August 27, 2024 (1)	—		516,818

Senior Convertible Notes - October 2024 (2)	33,623		2,475,162
Senior Convertible Notes - December 2024	30,443		250,000


Senior Convertible Notes - May 2025 (2)	895,497		—
Senior Convertible Notes - September 2025 (2)	100,926		—
Promissory Notes - Fermata Energy II LLC	570,616		—
Total outstanding principal balance	3,112,673		5,572,001
Less: unamortized debt issuance costs and discounts	(77,949)		(84,170)
Total debt	3,034,724		5,487,831
Less: current portion of long-term debt	2,194,224		4,647,331
Long-term debt, net of current portion	$	840,500	$	840,500

__________________

(1) Principal balance and interest was fully repaid as of March 31, 2025.

(2) Amount represents the fair value of the convertible notes.

(3) Amount includes accrued interest.

As of September 30, 2025, the total future maturities of the principal amounts of the debt obligations are as follows:


2025 (remaining three months)	$	1,623,608
2026	570,616
2027	840,500



	3,034,724

Term Loan

On August 9, 2024, November 27, 2024 and March 31, 2025, the Company entered into a Subordinated Business Loan and Security Agreement ("Term Loans") with Agile Lending, LLC, as lender, and Agile Capital Funding, LLC, as collateral agent. The August 9, 2024, November 27, 2024 and March 31, 2025 Term Loans are short-term, fixed interest rate obligations. Principal and interest on the Term Loans are payable in arrears weekly. The Term Loans are secured by certain of the Company's assets, and were evidenced by a subordinated secured promissory note.

The Term Loan contains customary affirmative and negative covenants. Among other things, these covenants restrict the Company's ability to incur certain types or amounts of indebtedness, incur liens on certain assets, dispose of material assets, enter into certain restrictive agreements, or engage in certain transactions with affiliates. Additionally, the Term Loan contains customary default provisions including, but not limited to, failure to pay interest or principal when due. The Company is in compliance with the Term Loan covenants as of September 30, 2025.

The following is a summary description of the key terms of the Term Loan:


Debt	Debt Origination Date	Maturity	Principal Amount Borrowed		Carrying Value		Weighted Weekly Average Interest Rate		Weighted Annual Average Interest Rate
Term loan	8/9/2024	3/6/2025	$	1,000,000	$	—	2.96	%	153.90	%
Term loan	11/27/2024	6/27/2025	$	1,000,000	$	—	2.96	%	153.90	%
Term loan	3/31/2025	3/31/2026	$	1,750,000	$	627,727	2.16	%	112.60	%

Interest expense paid on the Term Loan for the three and nine months ended September 30, 2025 was $277,573 and $1,073,408, respectively. Interest expense paid on the Term Loan for the three and nine months ended September 30, 2024 was $219,159.

As of September 30, 2025, the Company has repaid fully the principal balance and interest of the August 9, 2024 and November 27, 2024 Term Loans.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Promissory Notes - August 16, 2024

In connection with the formation of Deep Impact (see Note 1), Promissory Notes (each a “SPV Promissory Note”) with conversion option were issued to each of Gregory Poilasne and David Robson, the Chief Executive Officer and Chief Financial Officer of the Company (collectively, the “SPV Note Holders”), respectively, in exchange for up to an aggregate of $1,500,000, to further support project costs in exchange for their investment into Deep Impact. Each SPV Promissory Note was issued with an original principal amount of $750,000 (the “Principal Amount”). As of September 30, 2025, the Chief Executive Officer and Chief Financial Officer have funded $610,500 and $230,000, respectively, of the Promissory Notes.

The SPV Promissory Notes have a term of three years and bear interest at a rate of 17.5% per annum. The SPV Promissory Notes further provide that upon certain events of default, the SPV Note Holders shall have the option to convert the outstanding amounts on such SPV Promissory Notes for an aggregate of 101 membership units in Deep Impact, allocated pro rata to such Holder’s share of the aggregate outstanding principal amount under the SPV Promissory Notes. Additionally, pursuant to the Deep Impact governance documents, the SPV Note Holders will be entitled to a share of the Deep Impact’s 25% of the operating cash flows in addition to the interest amounts payable under the SPV Promissory Notes.

Interest expense on the SPV Promissory Notes for the three and nine months ended September 30, 2025 was $38,189 and $113,375, respectively. Interest expense on the SPV Promissory Notes for the three and nine months ended September 30, 2024 was $6,946.

In February 2025, under the existing SPV Promissory Note agreement, the Company issued promissory notes to each of Gregory Poilasne and David Robson, the Chief Executive Officer and Chief Financial Officer of the Company, respectively, in exchange for an aggregate of $266,000 (the "February Promissory Note"). Each February Promissory Note was issued with an original Principal Amount of $133,000 in exchange in cash to the Company, for aggregate gross proceeds of $266,000.

Interest expense on the February Promissory Notes for the three and nine months ended September 30, 2025 was $7,285 and $17,578, respectively.

On September 24, 2025, the Company repaid the principal balance and interest of the February Promissory Notes for a total amount repaid of $283,578 pursuant to which the Company transferred and assigned the Company’s right to certain receivable from Switch EV Ltd, a company which Nuvve used to have an investment.

Promissory Notes - August 27, 2024

On August 27, 2024, the Company issued promissory notes with conversion option to each of Gregory Poilasne and David Robson, the Chief Executive Officer and Chief Financial Officer of the Company, respectively, in exchange for an aggregate of $500,000 (the "Nuvve Promissory Notes"). Each Nuvve Promissory Note was issued with an original Principal Amount of $250,000. The Principal Amount of each Nuvve Promissory Note includes an original issue discount of $12,500, or 5.0%. In exchange for the Nuvve Promissory Notes, each Holder paid a purchase price of $237,500 (the “Non-OID Principal Amount”) in cash to the Company, for aggregate gross proceeds to the Company of $475,000.

The Nuvve Promissory Notes accrue interest at a rate of 10.5% per annum, subject to an increase to 12.5% upon the occurrence of an event of default (as that term is defined in the Nuvve Promissory Notes), and have a maturity date of October 31, 2024 (the “Maturity Date”). Pursuant to the Nuvve Promissory Notes, all accrued and unpaid interest and principal amount are payable in cash on the Maturity Date. If the Company consummates a Change of Control (as such term is defined in the Nuvve Promissory Notes), the outstanding balance of the Nuvve Promissory Note plus any unpaid accrued interest will become immediately due and payable.

Interest expense on the Nuvve Promissory Notes for the three and nine months ended September 30, 2025 was $4,333. Interest expense paid on the Nuvve Promissory Notes for the three and nine months ended September 30, 2024 was $16,875.

On January 31, 2025, the Company repaid the principal balance and interest of Nuvve Promissory Notes for a total amount repaid of $523,097.

Senior Convertible Notes - October 2024

In October 2024, the Company issued (i) senior convertible notes (the "October 2024 Notes") to certain accredited investors of the Company, pursuant to a securities purchase agreement, in exchange for an aggregate of $3,750,000 of a principal amount, and (ii) accompanying warrants to purchase shares of Common Stock (the “October 2024 Warrants”). The principal amount of the October 2024 Notes included an original issue discount of $375,000, or 10.00%, with net cash proceed to the Company of $3,375,000, which was funded on October 31, 2024.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

The Company's the Chief Executive Officer, Mr. Poilasne, participated as an investor and was issued an October 2024 Note in the principal amount of $250,000. The principal amount of the October 2024 Notes issued to Mr. Poilasne included an original issue discount of $25,000, or 10.00% with a net cash proceed to the Company of $225,000, which was funded on September 30, 2024.

The October 2024 Notes have a term of 18 months and bear interest at an effective rate of 8.00% per annum, and have a maturity date of March 31, 2026. Pursuant to the October 2024 Notes, all accrued and unpaid interest and principal amount are payable in cash on the maturity date. The October 2024 Notes are payable in 15 equal payments with the first payment starting on the fourth month after issuance of the October 2024 Notes. The holders of the October 2024 Notes have the option to convert any outstanding principal and unpaid accrued interest under the October 2024 Notes into shares of the Company’s common stock, at a conversion price of $3.402 per share. The conversion price of the October 2024 Notes is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the conversion price then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

In conjunction with the October 2024 Notes, the Company issued to the investors warrants to purchase an aggregate of 1,102,295 shares of Common Stock, representing 100.00% of the shares (the “Warrant Shares”) of Common Stock that each October 2024 Note is convertible into as of the issuance of the October 2024 Notes, at an exercise price of $3.78 per share (the “Exercise Price”), which was the most recent closing price of the Common Stock prior to the closing as reported by the Nasdaq Stock Market LLC (“Nasdaq”).

The Warrants Shares are exercisable immediately and will expire five years after the date of issuance and may be exercised on a cashless basis in the event of a fundamental transaction involving the Company or if the resale of the shares of common stock underlying the Warrants Shares is not covered by an effective registration statement. The Exercise Price is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the Exercise Price then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

Additionally, for so long as the October 2024 Notes or the October 2024 Warrants remain outstanding, the investors shall have the right (the “Additional Investment Right”), exercisable at any time and from time to time commencing after the six-month anniversary of the October 2024 Notes closing, to purchase up to an aggregate of $12,500,000 additional notes and warrants (the “Additional Notes” and “Additional Warrants,” respectively). The Additional Notes and Additional Warrants shall have the same terms as the October 2024 Notes and Warrants, except that the conversion price of the Additional Notes and the exercise price of the Additional Warrants shall each be equal to 95.00% of the average of the five lowest daily prices in the ten trading days prior to the date such investor exercises its Additional Investment Right.

The October 2024 Notes and October 2024 Warrants are recorded as a liability in the condensed consolidated balance sheet at fair value, with changes in fair value recorded in the consolidated statement of operations. See Note 4 for details of changes in fair value recorded in the consolidated statement of operations.

Interest expense on the October 2024 Notes for the three and nine months ended September 30, 2025 were $4,710 and $63,602, respectively. There was no interest expense paid on the October 2024 Notes for the three and nine months ended September 30, 2024.

As of September 30, 2025, the accredited investors have converted $3,763,614 of the October 2024 Notes into 2,494,678 of the Company's shares of common stock for an average conversion price of $1.638 per share pursuant to the securities purchase agreement.

As of September 30, 2025, the accredited investors have exercised 2,030,554 of the warrants related to the October 2024 Notes into 2,030,554 of the Company's shares of common stock for an average exercise price of $1.025 per share pursuant to the securities purchase agreement for total gross proceeds to the Company of $1,230,752.

Senior Convertible Notes - December 2024

On December 31, 2024, the Company entered into a securities purchase agreement (the “December Purchase Agreement”) with an accredited institutional and individual investors (the “December Investor”), pursuant to which the Company agreed to issue to the December Investor (i) a $250,000 principal amount (the “December Principal Amount”) senior convertible promissory note, carrying a 10.00% original issue discount (the “December Note”), convertible into shares of our common stock and (ii) an accompanying warrant (the “December Warrant”) to purchase shares of Common Stock (the “December Private Placement”).

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

On December 31, 2024, the Company closed the December Private Placement and issued the December Note and the December Warrant (the “Closing”).

The December Note has a term of 12 months and bear interest at an effective rate of 8.00% per annum, and have a maturity date of December 31, 2025. The December Note is convertible at the option of the December Investor, at any time, in whole or in part, into such number of shares of Common Stock equal to the principal amount of the note outstanding plus all accrued and unpaid interest at a conversion price equal to $2.931 per share. In conjunction with the December Note, the Company issued to the December Investor the December Warrants to purchase an aggregate of 85,287 shares of Common Stock, at an exercise price of $3.26 per share. Each of the conversion price of the December 2024 Note and exercise price of the December Warrant is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the conversion price or exercise price, as applicable, then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

Interest expense on the December Note for three and nine months ended September 30, 2025 was $5,508 and $16,878, respectively. There was no interest expense paid on the October 2024 Notes for the three and nine months ended September 30, 2024.

As of September 30, 2025, the accredited investors have converted $171,568 of the December 2024 Note into 171,568 of the Company's shares of common stock for an average conversion price of $1.00 per share pursuant to the securities purchase agreement.

Senior Convertible Notes - March 2025

On March 5, 2025, the Company issued to certain investors (i) an aggregate of $1,666,666.67 principal amount senior convertible promissory notes ("March 2025 Convertible Notes"), carrying a 10.00% original issue discount, convertible into shares of Common Stock, and (ii) accompanying warrants ("March 2025 Warrants") to purchase shares of Common Stock.

The March 2025 Convertible Notes have a term of 18 months with monthly installment payments and bear interest at an effective rate of 8.00% per annum which automatically increases to 18.00% per annum in the event of a default. The March 2025 Convertible Notes is convertible at the option of the investors, at any time, in whole or in part, into such number of shares of Common Stock equal to the principal amount of the note outstanding plus all accrued and unpaid interest at a conversion price equal to $2.02 per share. Each of the conversion price of the March 2025 Convertible Notes and the exercise price of the March 2025 Warrants is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the conversion price or exercise price, as applicable, then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

The March 2025 Warrants are exercisable for up to an aggregate of 100.0% of the shares of Common Stock that each March 2025 Convertible Note is convertible into as of the issuance date, at an exercise price of $2.02 per share, which represents 95.0% of the average of the five lowest trading prices in the ten trading days prior to the date the investors exercised their additional investment right, as set forth in the purchase agreement.

The March 2025 Convertible Notes and Warrants were recorded as a liability in the consolidated balance sheet at fair value, with changes in fair value recorded in the consolidated statement of operations. See Note 4 for details of changes in fair value recorded in the consolidated statement of operations.

Interest expense on the March 2025 Convertible Notes for three and nine months ended September 30, 2025 was zero and $19,316, respectively. There was no interest expense paid on the March 2025 Convertible Notes for the three and nine months ended September 30, 2024.

As of September 30, 2025, the accredited investors have converted all of the $1,675,392 of the March 2025 Convertible Notes into 2,227,379 of the Company's shares of common stock for an average conversion price of $0.744 per share pursuant to the securities purchase agreement.

As of September 30, 2025, the accredited investors have exercised 285,028 of the warrants related to the March 2025 Convertible Notes into 285,028 of the Company's shares of common stock for an average exercise price of $0.7394 per share pursuant to the securities purchase agreement for total gross proceeds to the Company of $210,750.

Senior Convertible Notes - April 2025

On April 28, 2025, the Company issued to certain investors (i) an aggregate of $1,444,444.44 principal amount senior convertible promissory notes ("April 2025 Convertible Notes"), carrying a 10.00% original issue discount, convertible into shares of Common Stock, and (ii) accompanying warrants ("April 2025 Warrants") to purchase shares of Common Stock.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

The April 2025 Convertible Notes have a term of 18 months with monthly installment payments and bear interest at an effective rate of 8.00% per annum which automatically increases to 18.00% per annum in the event of a default. The April 2025 Convertible Notes is convertible at the option of the investors, at any time, in whole or in part, into such number of shares of Common Stock equal to the principal amount of the note outstanding plus all accrued and unpaid interest at a conversion price equal to $0.8261 per share. The conversion price of the April 2025 Convertible Notes is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the conversion price then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

The April 2025 Warrants are exercisable for up to an aggregate of 100.0% of the shares of Common Stock that each April 2025 Convertible Note is convertible into as of the issuance date, at an exercise price of $0.8261 per share, which represents 95.0% of the average of the five lowest trading prices in the ten trading days prior to the date the investors exercised their additional investment right, as set forth in the purchase agreement. The exercise price of the April 2025 Warrants is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the exercise price then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

The April 2025 Convertible Notes and Warrants are recorded as a liability in the consolidated balance sheet at fair value, with changes in fair value recorded in the consolidated statement of operations. See Note 4 for details of changes in fair value recorded in the consolidated statement of operations.

Interest expense on the April 2025 Convertible Notes for three and nine months ended September 30, 2025 was zero and $9,192, respectively. There was no interest expense paid on the April 2025 Convertible Notes for the three and nine months ended September 30, 2024.

As of September 30, 2025, the accredited investors have converted all of the $1,450,302.68 of the April 2025 Convertible Notes into 1,953,223.00 of the Company's shares of common stock for an average conversion price of $0.7420 per share pursuant to the securities purchase agreement.

As of September 30, 2025, the accredited investors have exercised 769,546 of the warrants related to the April 2025 Convertible Notes into 769,546 of the Company's shares of common stock for an average exercise price of $0.7394 per share pursuant to the securities purchase agreement for total gross proceeds to the Company of $568,642.

Senior Convertible Notes - May 2025

On May 30, 2025, the Company issued to certain investors (i) an aggregate of $4,166,666.66 principal amount senior convertible promissory notes ("May 2025 Convertible Notes"), carrying a 10.00% original issue discount, convertible into shares of Common Stock, and (ii) accompanying warrants ("May 2025 Warrants") to purchase shares of Common Stock.

The May 2025 Convertible Notes have a term of 18 months with monthly installment payments and bear interest at an effective rate of 8.00% per annum which automatically increases to 18.0% per annum in the event of a default. The May 2025 Convertible Notes is convertible at the option of the investors, at any time, in whole or in part, into such number of shares of Common Stock equal to the principal amount of the note outstanding plus all accrued and unpaid interest at a conversion price equal to $0.7800 per share. The conversion price of the May 2025 Convertible Notes is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the conversion price then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

The May 2025 Warrants are exercisable for up to an aggregate of 100.00% of the shares of Common Stock that each May 2025 Convertible Note is convertible into as of the issuance date, at an exercise price of $0.7800 per share, which represents 95.0% of the average of the five lowest trading prices in the ten trading days prior to the date the investors exercised their additional investment right, as set forth in the purchase agreement. The exercise price of the May 2025 Warrants is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the exercise price then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

The May 2025 Convertible Notes and Warrants are recorded as a liability in the consolidated balance sheet at fair value, with changes in fair value recorded in the consolidated statement of operations. See Note 4 for details of changes in fair value recorded in the consolidated statement of operations.

Interest expense on the May 2025 Convertible Notes for three and nine months ended September 30, 2025 was $20,881 and $47,403, respectively. There was no interest expense paid on the May 2025 Convertible Notes for the three and nine months ended September 30, 2024.

As of September 30, 2025, the accredited investors have converted $3,072,978 of the May 2025 Convertible Notes into 6,077,289 of the Company's shares of common stock for an average conversion price of $0.616 per share pursuant to the securities purchase agreement.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

As of September 30, 2025, the accredited investors have exercised 50,000 of the warrants related to the May 2025 Convertible Notes into 50,000 of the Company's shares of common stock for an average exercise price of $0.1711 per share pursuant to the securities purchase agreement for total gross proceeds to the Company of $8,555.

Senior Convertible Notes - September 2025

On September 10, 2025, the Company issued to certain investors (i) an aggregate of $111,111.00 principal amount senior convertible promissory notes ("September 2025 Convertible Notes"), carrying a 10.00% original issue discount, convertible into shares of Common Stock, and (ii) accompanying warrants ("September 2025 Warrants") to purchase shares of Common Stock.

The September 2025 Convertible Notes have a term of 18 months with monthly installment payments and bear interest at an effective rate of 8.00% per annum which automatically increases to 18.00% per annum in the event of a default. The September 2025 Convertible Notes is convertible at the option of the investors, at any time, in whole or in part, into such number of shares of Common Stock equal to the principal amount of the note outstanding plus all accrued and unpaid interest at a conversion price equal to $0.1711 per share. The conversion price of the September 2025 Convertible Notes is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the conversion price then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

The September 2025 Warrants are exercisable for up to an aggregate of 100.00% of the shares of Common Stock that each September 2025 Convertible Note is convertible into as of the issuance date, at an exercise price of $0.1711 per share, which represents 95.00% of the average of the five lowest trading prices in the ten trading days prior to the date the investors exercised their additional investment right, as set forth in the purchase agreement. The exercise price of the September 2025 Warrants is subject to full ratchet antidilution protection, subject to certain price limitations required by Nasdaq rules and regulations and certain exceptions, upon any subsequent transaction at a price lower than the exercise price then in effect and standard adjustments in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes.

The September 2025 Convertible Notes and Warrants are recorded as a liability in the consolidated balance sheet at fair value, with changes in fair value recorded in the consolidated statement of operations. See Note 4 for details of changes in fair value recorded in the consolidated statement of operations.

Interest expense on the September 2025 Convertible Notes for three and nine months ended September 30, 2025 was zero. There was no interest expense paid on the September 2025 Convertible Notes for the three and nine months ended September 30, 2024.

Promissory Notes - Fermata Energy II LLC

On April 23, 2025, promissory notes with conversion option were issued to certain employees of the Company, including Gregory Poilasne, the Chief Executive Officer of the Company (collectively, the “Fermata Promissory Notes”), respectively, in exchange for up to an aggregate of $547,058, to further support project costs in exchange for their investment into Fermata Energy II LLC. Each Fermata Promissory Note was issued carrying a 15.00% original issue discount.

The Fermata Promissory Notes have a term of 12 months and bear interest at a rate of 10.00% per annum.

Interest expense on the Fermata Promissory Notes for the three and nine months ended September 30, 2025 was $13,676 and $23,858, respectively. There was no interest expense on the Fermata Promissory Notes for the three and nine months ended September 30, 2024.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 11 – Stockholders’ Deficit

Reverse Stock Split

The Reverse Stock Splits did not affect the number of authorized shares of the Company's common stock or the par value of the common stock. Following the January 2024 Reverse Stock Split's effectiveness on January 19, 2024, all references in the consolidated financial statements to number of shares of common stock issued or outstanding, price per share and weighted average number of shares outstanding prior to the 1- for - 40 reverse split have been adjusted to reflect the stock split on a retroactive basis as of the earliest period presented.

Additionally, at the Company’s Annual Meeting of Stockholders held on September 9, 2024, the Company’s stockholders approved a proposal to authorize a reverse stock split of the Company’s common stock, and the Board approved a 1-for-10 reverse split ratio for the September 2024 Reverse Stock Split, which became effective September 17, 2024. Therefore, in addition to the January Reverse Stock Split, following the September 2024 Reverse Stock Split's effectiveness on September 17, 2024, all references in the consolidated financial statements to number of common shares issued or outstanding, price per share and weighted average number of shares outstanding prior to the 1- for - 10 September 2024 Reverse Stock Split have been adjusted to reflect the stock split on a retroactive basis as of the earliest period presented.

No fractional shares were issued in connection with the reverse stock splits and each fractional share resulting from the reverse stock splits were rounded up to the next whole share. As a result of the reverse stock split, 192,222 additional shares of common stock were issued in lieu of fractional shares.

Authorized Shares

As of September 30, 2025, the Company has authorized two classes of stock, Common Stock, and Preferred Stock. The total number of shares of all classes of capital stock which the Company has authority to issue is 201,000,000, of which 200,000,000 authorized shares are Common Stock with a par value of $0.0001 per share (“Common Stock”), and 1,000,000 authorized shares are Preferred Stock of the par value of $0.0001 per share (“Preferred Stock”). Please see Note 11, “Stockholders' Equity,” in the Notes to Consolidated Financial Statements included in the Company’s 2024 Form 10-K for a detailed discussion of the Company’s stockholders' equity.

On February 21, 2025, the shareholders of the Company, in a special election approved an amendment of the Company’s Amended and Restated Certificate of Incorporation to increase the total number of authorized Common Stock from 100,000,000 shares to 200,000,000 shares.

July 2025 Registered Public Offering

On July 11, 2025, the Company, entered into an underwriting agreement (the “July 2025 Underwriting Agreement”) with Lucid Capital Markets, LLC (“Lucid”) pursuant to which the Company issued and sold to Lucid 3,044,463 shares (the “Shares”) of Common Stock and 1,984,940 pre-funded warrants (each representing the right to purchase one Share of Common Stock at an exercise price of $0.0001, the “Pre-Funded Warrants”) to purchase shares of Common Stock, at an offering price of $0.95 per Share (or $0.9499 per Pre-Funded Warrant), and granted to Lucid an option for the issuance and sales of up to 754,411 additional Shares or Pre-Funded Warrants (the “Option”) to be sold by the Company (the “July 2025 Offering”). The July 2025 Offering closed on July 14, 2025. The aggregate gross proceeds to the Company from the July 2025 Offering were approximately $5.5 million, before deducting underwriting discounts of 8.0% of the price to the public and any other expenses payable by the Company in connection with the July 2025 Offering. Pursuant to the July 2025 Underwriting Agreement the Company also agreed to issue to Lucid common stock purchase warrants (the “Representative’s Warrant”) to purchase up to 5.0% of the securities sold in the July 2025 Offering at an exercise price of $1.05 per share of Common Stock.

February 2024 Public Offering

On January 31, 2024, the Company entered into an underwriting agreement (the “January 2024 Underwriting Agreement”) with Craig-Hallum Capital Group LLC (“Craig-Hallum”) regarding an underwritten public offering of its securities (the “Offering”). The Offering was conducted pursuant to our Registration Statement on Form S-1 filed with the SEC, which was declared effective as of January 31, 2024. On February 2, 2024, the Company completed the Offering and received gross proceeds of approximately $9.6 million prior to deducting underwriting discounts and commissions and offering expenses. Craig-Hallum received underwriting discounts and commissions equal to 7.0% of the gross proceeds of the Offering, and is further entitled to receive 7.0% of the gross proceeds received by the Company in connection with the exercise of any of the outstanding Series B Warrants issued in the Offering.

As noted above, on January 31, 2024, the Company entered into the January 2024 Underwriting Agreement regarding the Offering which was comprised of the followings:

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

1.303,500 shares of common stock;

2.176,500 pre-funded warrants (“Pre-Funded Warrants”) to purchase shares of common stock;

3.480,000 Series A Warrants (“Series A Warrants”) to purchase shares of common stock, with an initial exercise price of $20.00 per share and a term of five years following the issuance date;

4.480,000 Series B Warrants (“Series B Warrants”) to purchase shares of common stock with an exercise price of $20.00 per share and a term of nine months following the issuance date; and

5.480,000 Series C Warrants (“Series C Warrants”) to purchase shares of common stock with an exercise price of $20.00 per share and a term of five years following the issuance date, subject to early expiration as described below.

Each share of common stock and Pre-Funded Warrant issued in the Offering was accompanied by a Series A Warrant to purchase one share of common stock, a Series B Warrant to purchase one share of common stock and a Series C Warrant to purchase one share of common stock. The combined price per share of Common Stock and the accompanying Series A Warrant, Series B Warrant and Series C Warrant was $20.00. The combined price per share of each Pre-Funded Warrant and accompanying Series A Warrant, Series B Warrant, and Series C Warrant was equal to $19.9990, and the exercise price of each Pre-Funded Warrant is $0.0010 per share. The Series C Warrants may only be exercised to the extent and in proportion to a holder of the Series C Warrants exercising its Series B Warrants, and are subject to an early expiration of nine months, in proportion and only to the extent any Series C Warrants expire unexercised. In addition, Craig-Hallum was granted warrants to purchase up to 48,000 shares of common stock (the “Underwriter Warrants”) at an exercise price of $20.00 per share. The Underwriter Warrants have a term of five years and are immediately exercisable, provided that 24,000 of the shares of common stock underlying the Underwriter Warrants shall only be exercisable pro rata upon the exercise of the Series B Warrants issued in the Offering.

The fair value of the Series A, B and C Warrants are recorded as a liability in the condensed consolidated balance sheets with changes in fair value recorded in the condensed consolidated statements of operations as the warrants are deemed not to be indexed to the Company’s common stock. See Note 4 for details of changes in fair value of the warrants recorded in the condensed consolidated statement of operations.

Warrants - Public and Private

In connection with its initial public offering on February 19, 2020, Newborn sold 14,375 units, which included one warrant to purchase Newborn’s common stock (the “Public Warrants”). Also, on February 19, 2020, NeoGenesis Holding Co., Ltd., Newborn’s sponsor (“the Sponsor”), purchased an aggregate of 681 private units, each of which included one warrant (the “Private Warrants”), which have the same terms as the Public Warrants. Upon completion of the merger between Nuvve and Newborn, the Public Warrants and Private Warrants were automatically converted to warrants to purchase Common Stock of the Company.

The terms of the Private Warrants are identical to the Public Warrants as described above, except that the Private Warrants are not redeemable so long as they are held by the Sponsor or its permitted transferees. Concurrently with the execution of the Merger Agreement on November 11, 2020, Newborn entered into subscription agreements with certain accredited investors pursuant to which the investors agreed to purchase 3,563 of Newborn’s common stock, at a purchase price of $4,000.00 per share, for an aggregate purchase price of $14,250,000 (the "PIPE"). Upon closing of the PIPE immediately prior to the closing of the Business Combination, the PIPE investors also received 1.9 PIPE Warrants to purchase the Company’s Common Stock for each share of Common Stock purchased. The PIPE Warrants are each exercisable for one-half of a common share at $4,600.00 per share and have the same terms as described above for the Public Warrants. The PIPE investors received demand and piggyback registration rights in connection with the securities issued to them.

Because the Private Warrants have dissimilar terms with respect to the Company’s redemption rights depending on the holder of the Private Warrants, the Company determined that the Private Warrants are required to be carried as a liability in the condensed consolidated balance sheet at fair value, with changes in fair value recorded in the condensed consolidated statement of operations. The Private Warrants are reflected as a liability in the condensed consolidated balance sheet as of September 30, 2025 and the change in the fair value of the Private Warrants is reflected in the condensed consolidated statement of operations. See Note 4 for details of changes in fair value of the Private Warrants recorded in the condensed consolidated statement of operations.

In May 2025, the Company granted warrants to purchase an aggregate of 11,000,004 shares of warrants to certain consultants of the Company as compensation for cryptocurrency strategy related consulting services rendered (the "May 2025 Consulting Warrants"). The fair value of the May 2025 Consulting Warrants of $8.19 million is equity classified in the condensed consolidated balance sheet as of September 30, 2025, and reflected as operating expenses in the condensed consolidated statement of operations.

In conjunction with the issuance of September 2025 Convertible Notes, May 2025 Convertible Notes, April 2025 Convertible Notes, March 2025 Convertible Notes, December 2024 Convertible Notes and October 2024 Convertible Notes (see Note 10),

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

the Company issued to the investors warrants to purchase an aggregate of 649,393, 5,341,879, 1,953,537, 1,777,750, 277,780 and 2,076,036 shares of Common Stock, respectively, at an exercise price of $0.17, $0.78, $0.74, $0.74, $1.00 and $0.74 per share, respectively. Such warrants are reflected as a liabilities in the condensed consolidated balance sheet as of September 30, 2025, and the change in the fair value of the private warrants for the three months ended September 30, 2025 in the condensed consolidated statements of operations. See Note 4 for details of changes in fair value of the private warrants recorded in the condensed consolidated statement of operations.

The following table is a summary of the number of shares of the Company’s Common Stock issuable upon exercise of warrants outstanding at September 30, 2025, including adjusted exercise price for full ratchet antidilution protection for some warrants as disclosed in Note 10:


	Number of Warrants	Number of Warrants Exercised	Number of Warrants Cancelled	Number of Warrants Exercisable	Exercise Price	Adjusted Exercise Price	Adjusted Number of Warrants Exercisable	Expiration Date
Public Warrants	7,188	—	—	7,188	$4,600.00	$4,600.00	7,188	March 19, 2026
Private Warrants - February 2020	341	—	—	341	$4,600.00	$4,600.00	341	March 19, 2026

PIPE Warrants	3,384	—	—	3,384	$4,600.00	$4,600.00	3,384	March 19, 2026





2022 July Institutional/Accredited Investor Warrants	10,000	—	—	10,000	$1,500.00	$1,500.00	10,000	January 29, 2028
Underwriter Warrants - February 2024 offering	48,000	—	22,500	25,500	$20.00	$20.00	25,500	February 2, 2029

2024 February Institutional/Accredited Investor Warrants - series A	480,000	—	—	480,000	$20.00	$20.00	480,000	February 2, 2029

2024 February Institutional/Accredited Investor Warrants - series C	480,000	—	450,000	30,000	$20.00	$20.00	30,000	February 2, 2029
2024 October Institutional/Accredited Investor Warrants	2,076,036	1,700,351	—	375,685	$0.74	$0.1711	1,623,501	October 31, 2029
2024 December Institutional/Accredited Investor Warrants	277,780	—	—	277,780	$1.00	$1.00	277,780	December 31, 2029
2025 March Institutional/Accredited Investor Warrants	1,777,750	285,028	—	1,492,722	$0.74	$0.1711	6,483,939	March 5, 2030
2025 April Institutional/Accredited Investor Warrants	1,953,537	769,546	—	1,183,991	$0.74	$0.1711	4,980,253	April 28, 2030
2025 May Institutional/Accredited Investor Warrants	5,341,879	50,000	—	5,291,879	$0.78	$0.1711	24,102,223	May 30, 2030
2025 July Institutional/Accredited Investor Pre-funded Warrants	1,984,940	1,507,795	—	477,145	$0.0001	$0.0001	477,145	Until Exercised in Full
2025 September Institutional/Accredited Investor Warrants	649,393	—	—	649,393	$0.1711	$0.1711	649,393	September 10, 2030
May 2025 Consulting Warrants	3,000,000	—	—	3,000,000	$1.05	$1.05	3,000,000	May 7, 2030
May 2025 Consulting Warrants	3,000,000	—	—	3,000,000	$1.25	$1.25	3,000,000	May 7, 2030
May 2025 Consulting Warrants	3,000,000	—	—	3,000,000	$1.50	$1.50	3,000,000	May 7, 2030
May 2025 Consulting Warrants	666,668	—	—	666,668	$1.00	$1.00	666,668	May 18, 2030
May 2025 Consulting Warrants	666,668	—	—	666,668	$1.25	$1.25	666,668	May 18, 2030
May 2025 Consulting Warrants	666,668	—	—	666,668	$1.50	$1.50	666,668	May 18, 2030
	26,090,232	4,312,720	472,500	21,305,012			50,150,651

Unit Purchase Option

On February 19, 2020, Newborn sold to the underwriters of its initial public offering (the “IPO”) for $100, (pre-stock split) a unit purchase option ("UPO") to purchase up to a total of 791 units at $4,600.00 per unit (or an aggregate exercise price of $3,636,875) commencing on the date of Newborn's initial business combination, March 19, 2021, and expiring February 13, 2025. Each unit issuable upon exercise of the UPO consists of one and one-tenth of a share of the Company's common stock and one warrant to purchase one share of the Company's common stock at the exercise price of $4,600.00 per share. The warrant has the same terms as the Public Warrant. In no event will the Company be required to net cash settle the exercise of the UPO or the warrants underlying the UPO. The holders of the unit purchase option have demand and "piggy back" registration rights for periods of five and seven years, respectively, from the effective date of the IPO, including securities directly and indirectly issuable upon exercise of the unit purchase option. The UPO is classified within stockholders’ equity as “additional paid-in capital” in accordance with ASC 815-40, Derivatives and Hedging-Contracts in an Entity’s Own Equity, as the UPO is indexed to the Company’s common stock and meets the conditions for equity classification.

Treasury Stock

The Company's Board authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.

The share repurchase activity pursuant to this authorization is as follows:

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)



	September 30, 2025		December 31, 2024
Beginning balance	1,680		—
Shares repurchased	—		1,680
Average purchase price per share	$	—	$	0.0001
Amount spent on repurchased shares	$	—	$	0.17
Aggregate Board of Directors repurchase authorizations during the period	—		$	1,680
Ending balance	1,680		1,680

The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of stockholders' equity.

Preferred Class A Units - Fermata Energy II LLC

In connection with the acquisition of Fermata in April 2025, 4,900,000 units of preferred class A units, which is also the total number of authorized preferred class A units, were issued to the former debt holders of the Seller. See Note 20 for details. The preferred class A units are nonconvertible and nonredeemable, and does not pay dividends. The preferred class A unit holders are entitled to an accrued compounded 10.0% annual preferred return, and certain distributions in the event of profit until they are fully paid back their initial capital contributions which will be the final distribution and termination of their preferred class A unit holdings.

Class B Units - Nuvve New Mexico LLC

In connection with the formation of Nuvve New Mexico LLC in April 2025, class B units of up to 2,500,000 were authorized to be issued to members admitted into the Nuvve New Mexico LLC through subscription as investors. The class B units are nonconvertible and nonredeemable, and does not pay dividend. The class B unit holders are entitled to an accrued cumulative 18.0% annual preferred return on unreturned capital contributions. As of September 30, 2025, two members have been admitted as a Class B unit members with an aggregate subscription of 150,000 Class B units at $1.00 per unit.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 12 – Stock Option Plan

In 2010, the Company adopted the 2010 Equity Incentive Plan (the “2010 Plan”), which provides for the grant of restricted stock awards, stock options, and other share-based awards to employees, consultants, and directors. In November 2020, the Board extended the term of the 2010 Plan to July 1, 2021. In 2021, the Company adopted the 2020 Equity Incentive Plan (the “2020 Plan”), which provides for the grant of restricted stock awards, incentive and non-statutory stock options, and other share-based awards to employees, consultants, and directors. In August 2025, the 2020 Plan was amended, as approved by shareholders, to increase the shares of common stock reserved for issuance under the plan by 14,944,592 shares. As of September 30, 2025, there is an aggregate of 15,000,000 shares of common stock reserved for issuance under the 2020 Plan. All options granted to date have a ten year contractual life and vesting terms of four years. In general, vested options expire if not exercised 90 days after termination of service. A total of 14,494,098 shares of common stock remained available for future issuance under the 2020 Plan as of November 8, 2025. Forfeitures are accounted for as they occur.

Stock-based compensation expense recognized in selling, general, and administrative, and research and development are as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Options	$	8,124	$	598,588	$	576,805	$	1,638,820
Restricted stock	237,500		2,487		237,500		290,443
Stock options - modified options	—		—		—		169
Profit interest units(1)	—		—		—		62,452
Total	$	245,624	$	601,075	$	814,305	$	1,991,884

__________________

(1) Profit interest is related to Levo which has been dissolved as an entity. See Note 18.

The following is a summary of the stock option activity under the 2010 Plan for the nine months ended September 30, 2025:


	Shares	Weighted- Average Exercise Price per Share($)	Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value($)
Outstanding - December 31, 2024	1,916	1,033.97	2.54	—
Granted	—	—	—	—
Exercised	—	—	—	—
Forfeited	—	—	—	—
Expired/Cancelled	(747)	508.47	—	—
Outstanding - September 30, 2025	1,169	1,369.78	2.94	—

Options Exercisable at September 30, 2025	1,169	1,369.78	2.94	—
Options Vested at September 30, 2025	1,169	1,369.78	2.94	—

The weighted-average grant-date fair value of options granted during the nine months ended September 30, 2025 was zero.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

The following is a summary of the stock option activity under the 2020 Plan for the nine months ended September 30, 2025:


	Shares	Weighted- Average Exercise Price per Share ($)	Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value($)
Outstanding - December 31, 2024	4,743	3,874.89	6.68	—
Granted	—	—	—	—
Exercised	—	—	—	—
Forfeited	—	—	—	—
Expired/Cancelled	(10)	2,708.00	—	—
Outstanding - September 30, 2025	4,733	3,877.35	5.95	—

Options Exercisable at September 30, 2025	3,746	4,879.38	5.72	—
Options Vested at September 30, 2025	3,746	4,879.38	5.72	—

The weighted-average grant-date fair value of options granted during the nine months ended September 30, 2025 was zero.

During the year ended December 31, 2021, 4,100 options were modified to lower the exercise price by $240.00 per share, which resulted in $246,000 of incremental compensation cost to be recognized over the remaining vesting period. The amount of additional compensation expense for the three and nine months ended September 30, 2024, was $169.

Other Information:


	Nine Months Ended September 30,
	2025		2024
Amount received from option exercised	$	—	$	—

	September 30, 2025				Weighted average remaining recognition period
Total unrecognized options compensation costs	$	16,358			1.58

No amounts relating to the 2010 Plan or 2020 Plan have been capitalized. Compensation cost is recognized over the requisite service period based on the fair value of the options.

The Company did not have any nonvested restricted stock units as of the nine months ended September 30, 2025.


	Shares	Weighted- Average Grant Date Fair Value($)
Nonvested at December 31, 2024	—	—
Granted	500,000	0.48
Vested/Release	(500,000)	—
Cancelled/Forfeited	—	—
Nonvested and Outstanding at September 30, 2025	—	—

As of September 30, 2025, there was zero of total unrecognized compensation cost related to nonvested restricted stock.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 13 – Income Taxes


	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Income tax expense	$	—		$	—		$	—		$	—
Effective tax rate	0.0		%	0.0		%	0.0		%	0.0		%

The effective tax rate used for interim periods is the estimated annual effective tax rate, based on current estimate of full year results, except that taxes related to specific events, if any, are recorded in the interim period in which they occur. The effective tax rate differed from the U.S. federal statutory tax rate primarily due to operating losses that receive no tax benefit as a result of a valuation allowance recorded for such losses.

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes (“ASC 740”). Under the provisions of ASC 740, management is required to evaluate whether a valuation allowance should be established against its deferred tax assets. The Company currently has a full valuation allowance against its deferred tax assets. As of each reporting date, the Company’s management considers new evidence, both positive and negative, that could impact management’s view with regard to future realization of deferred tax assets. For the nine months ended September 30, 2025, there was no material change from the year ended December 31, 2024 in the amount of the Company’s deferred tax assets that are not considered to be more likely than not to be realized in future years.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework, and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. We are currently assessing the impact of the OBBBA on our consolidated financial statements, and do not expect the OBBBA to have a significant impact.

NUVVE HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 14 – Net Loss Per Share Attributable to Common Stockholders

The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three and nine months ended September 30, 2025 and 2024:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024

Net loss attributable to Nuvve Holding Corp. common stockholders	$	(4,507,260)	$	(1,649,843)	$	(24,759,063)	$	(12,327,595)
Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted	18,557,638		666,894		8,954,465		567,486
Net Loss per share attributable to Nuvve common stockholders, basic and diluted	$	(0.24)	$	(2.47)	$	(2.76)	$	(21.72)

The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2025	2024	2025	2024
Stock options issued and outstanding	5,902	6,834	5,902	6,834
Nonvested restricted stock issued and outstanding	—	—	—	—
Public warrants	7,188	7,188	7,188	7,188
Private warrants - February 2020	341	341	341	341
Private pre-funded warrants - July 2024	—	30,000	—	30,000
PIPE warrants	3,384	3,384	3,384	3,384


2022 July Institutional/Accredited Investor Warrants	10,000	10,000	10,000	10,000

Underwriter Warrant - February 2024 offering	25,500	48,000	25,500	48,000
2024 February Institutional/Accredited Investor Warrants - series A	480,000	480,000	480,000	480,000
2024 February Institutional/Accredited Investor Warrants - series B	—	450,000	—	450,000
2024 February Institutional/Accredited Investor Warrants - series C	30,000	480,000	30,000	480,000
2024 October Institutional/Accredited Investor Warrants	1,623,501	—	1,623,501	—
2024 December Institutional/Accredited Investor Warrants	277,780	—	277,780	—
2025 March Institutional/Accredited Investor Warrants	6,483,939	—	6,483,939	—
2025 April Institutional/Accredited Investor Warrants	4,980,253	—	4,980,253	—

Nuvve Holding Corp. 10-Q